Obstetrics, gynecology, andrology, sexual and reproductive health

Breast diseases

Guidelines, reviews, epidemiology

 

Benign breast diseases

• Brazil
  • Clinics
    • Management of benign and suspicious breast lesions during the coronavirus disease pandemic: recommendations for triage and treatment [2020]
• Canada
  • Canadian Journal of Surgery
    • A survey of Canadian breast health professionals’ recommendations for high-risk benign breast disease [2019]
• China
  • Chinese Medical Journal
    • Clinical practice guideline for breast fibroadenoma: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 [2021]
• France
  • Archive ouverte HAL
    • Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors [2016]
• Germany
  • Breast Care
    • Benign Breast Tumours - Diagnosis and Management [2018]
• United Kingdom
  • Association of Breast Surgery
    • Guidance and pathways for the assessment of children with breast symptoms [2021]
    • Management of Fibroadenomas [2019]
    • Guidelines for the investigation and management of spontaneous nipple discharge in the absence of a breast lump [2019]
  • National Institute for Health and Care Excellence
    • High-intensity focused ultrasound for symptomatic breast fibroadenoma [2017]
• United States
  • Breast Cancer Research and Treatment
    • Pathologic Discordance to Clinical Management Decisions Suggests Overtreatment in Pediatric Benign Breast Disease [2019]
• {Related topics}
  • Guidelines
    • Mastitis
    • Mammography
    • Gynecomastia
    • Breast plastic surgery
    • Breast imaging
    • Breast cancer
    • Breast biopsy, breast pathology

Breast biopsy, breast pathology

• Australasia
  • Royal College of Pathologists of Australasia
    • Breast
• Australia
  • Cancer Australia
    • Position Statement on the use of fine needle aspiration (FNA) and core biopsy of the breast in the BreastScreen Australia program [2020]
    • High level review of evidence and guidelines to inform the Position Statement on the use of fine needle aspiration (FNA) and core biopsy of the breast in the BreastScreen Australia program [2020]
• Canada
  • Current Oncology
    • Testing for her2 in breast cancer: current pathology challenges faced in Canada [2012]
• China
  • Breast
    • Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis [2020]
  • Chinese Medical Journal
    • Clinical practice guidelines for ultrasound-guided vacuum-assisted breast biopsy: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
• Europe
  • European Society of Breast Imaging
    • Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging [2020]
• India
  • Indian Journal of Medical Research
    • Stereotactic breast biopsy: A review & applicability in the Indian context [2021]
• International
  • Annals of Oncology
    • Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration [2015]
  • Breast Cancer Research and Treatment
    • First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions) [2016]
  • Breast Health Global Initiative
    • Can pathology diagnostic services for cancer be stratified and serve global health? [2020]
  • Histopathology
    • Phyllodes tumours of the breast: a consensus review [2016]
    • Breast lesions of uncertain malignant nature and limited metastatic potential: Proposals to improve their recognition and clinical management [2016]
  • International Academy of Cytology
    • IAC Standardized Reporting of Breast Fine-Needle Aspiration Biopsy Cytology [2017]
  • International Collaboration on Cancer Reporting
    • Invasive Carcinoma of the Breast [2022]
    • Ductal Carcinoma In Situ, Variants of Lobular Carcinoma In Situ and Low Grade Lesions [2021]
  • Modern Pathology
    • Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group [2015]
• Iran
  • World Journal of Surgical Oncology
    • Chronological changes and trend of breast cancer clinics and pathology among Iranian women during 22 years from the largest breast cancer registry in Iran [2019]
• Italy
  • Pathologica
    • Pathological examination of breast cancer samples before and after neoadjuvant therapy: recommendations from the Italian Group for the Study of Breast Pathology - Italian Society of Pathology (GIPaM-SIAPeC) [2022]
• New Zealand
  • Ministry of Health New Zealand
    • Report of the National Panel to review Breast Biopsy Errors [2012]
• Sub-Saharan Africa
  • BMC Health Services Research
    • Breast cancer pathology services in sub-Saharan Africa: a survey within population-based cancer registries [2020]
• Switzerland
  • Acta Radiologica
    • Lesions with unclear malignant potential (B3) after minimally invasive breast biopsy: evaluation of vacuum biopsies performed in Switzerland and recommended further management [2015]
• United Kingdom
  • Association of Breast Surgery
    • Best Practise Guidelines for Surgeons in Breast Cancer Screening [2018]
  • Journal of Clinical Pathology
    • Updated UK Recommendations for HER2 assessment in breast cancer [2015]
  • National Institute for Health and Care Excellence
    • MammaTyper in vitro diagnostic test for determining breast cancer subtypes [2018]
    • Image-guided radiofrequency excision biopsy of breast lesions [2009]
  • Public Health England
    • Technical evaluation of Hologic Affirm prone biopsy system
    • Breast screening: how to record vacuum-assisted excisions
  • Royal College of Pathologists
    • Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening [2021]
    • Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer (low-res) [2016]
    • Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer (high-res) [2016]
• United States
  • Agency for Healthcare Research and Quality
    • Core-Needle Biopsy for Breast Abnormalities [2016]
  • American College of Radiology
    • ACR Practice Parameter for the Performance of Ultrasound-Guided Percutaneous Breast Interventional Procedures
    • ACR Practice Parameter for the Performance of Stereotactic- Guided Breast Interventional Procedure
    • ACR Practice Parameter for the Performance of Magnetic Resonance Imaging-Guided Breast Interventional Procedures
  • Annals of Surgical Oncology
    • Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer [2018]
  • BMC Women's Health
    • Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS) [2013]
  • Breast
    • Surgical Margin Reporting in Breast Conserving Surgery: Does compliance with guidelines affect re-excision and mastectomy rates? [2015]
  • Breast Cancer Surveillance Consortium
    • Trends in Breast Tissue Sampling and Pathology Diagnoses among Women Undergoing Mammography in the U.S.: A Report from the Breast Cancer Surveillance Consortium [2015]
  • CA: A Cancer Journal for Clinicians
    • Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual [2017]
  • Radiology
    • Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic [2021]
• {Related topics}
  • Guidelines
    • Sentinel lymph node biopsy
    • Breast cancer diagnosis
    • Breast cancer
    • Benign breast diseases

Breast cancer

• Africa
  • Breast Care
    • A Review on Breast Cancer Care in Africa [2015]
  • Infectious Agents and Cancer
    • An update on the management of breast cancer in Africa [2017]
• Asia
  • Asia-Pacific Journal of Oncology Nursing
    • The Effectiveness of Support Groups in Asian Breast Cancer Patients: An Integrative Review [2016]
  • European Society for Medical Oncology
    • Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS [2020]
• Australia
  • Australian Institute of Health and Welfare
    • Breast cancer in young women: key facts about breast cancer in women in their 20s and 30s [2015]
  • Cancer Australia
    • Breast Cancer: a handbook for Aboriginal and Torres Strait Islander Health Workers [2022]
    • Shared follow-up care for early breast cancer: summary of evidence [2019]
    • Influencing best practice in breast cancer [2016]
    • Clinical guidance for the management of lobular carcinoma in situ [2016]
    • Learner’s Guide: Providing information and support to Aboriginal and Torres Strait Islander women with breast cancer [2012]
    • Facilitator’s Guide: Providing information and support to Aboriginal and Torres Strait Islander women with breast cancer [2012]
• Bosnia and Herzegovina
  • Bosnian Journal of Basic Medical Sciences
    • 2020 consensus guideline for optimal approach to the diagnosis and treatment of HER2-positive breast cancer in Bosnia and Herzegovina [2020]
• Canada
  • BC Cancer Agency
    • Breast Cancer
  • BCGuidelines
    • Breast Disease and Cancer: Diagnosis [2013]
    • Breast Cancer: Management and Follow-Up [2013]
  • Canadian Cancer Society
    • Breast cancer
  • Canadian Family Physician
    • Primary care physician use across the breast cancer care continuum. CanIMPACT study using Canadian administrative data [2016]
  • Journal of the National Cancer Institute
    • Out-of-Pocket Costs in the Year After Early Breast Cancer Among Canadian Women and Spouses [2013]
  • Public Health Agency of Canada
    • Breast Cancer
• China
  • Annals of Translational Medicine
    • National consensus in China on diagnosis and treatment of patients with advanced breast cancer [2015]
  • Cancer
    • Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018) [2020]
  • Chinese Journal of Cancer Research
    • Chinese guidelines for diagnosis and treatment of breast cancer 2018 (English version) [2019]
  • Chinese Medical Journal
    • Clinical practice guidelines for ductal carcinoma in situ: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
    • Clinical practice guidelines for diagnosis and treatment of invasive breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
• Costa Rica, Mexico
  • PLoS ONE
    • Cost-Effectiveness of Breast Cancer Control Strategies in Central America: The Cases of Costa Rica and Mexico [2014]
• Cuba
  • International Journal of Clinical and Experimental Medicine
    • Application of hazard models for patients with breast cancer in Cuba [2011]
• Denmark
  • Clinical Epidemiology
    • Danish Breast Cancer Cooperative Group [2016]
• Developing countries
  • World Journal of Clinical Oncology
    • Challenges to the early diagnosis and treatment of breast cancer in developing countries [2014]
• Eastern Europe
  • SAGE Open Medicine
    • Comparative analysis of the access to health-care services and breast cancer therapy in 10 Eastern European countries [2020]
• Eastern Mediterranean
  • WHO Regional Office for the Eastern Mediterranean
    • Guidelines for management of breast cancer [2006]
• Europe
  • Breast
    • Why is appropriate healthcare inaccessible for many European breast cancer patients? – The EBCC 12 manifesto [2021]
    • The requirements of a specialist breast centre [2020]
    • Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe [2020]
    • New approaches for improving outcomes in breast cancer in Europe [2015]
  • Breast Cancer Research and Treatment
    • Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review [2020]
  • European Society for Medical Oncology
    • ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4) [2020]
    • ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer [2020]
    • Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2019]
    • ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3) [2017]
    • Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2015]
    • ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) [2014]
    • Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [2012]
  • European Society of Breast Cancer Specialists
    • The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer [2012]
  • Journal of Obstetrics and Gynaecology of India
    • Guidance and Standards for Breast Cancer Care in Europe [2020]
• France
  • Clinical Breast Cancer
    • Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients [2020]
  • European Journal of Breast Health
    • Breast Cancer Management during the COVID 19 Pandemic: French Guidelines [2020]
  • PLoS ONE
    • Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France [2019]
• Gambia
  • BMC Health Services Research
    • Geospatial analysis and impact of targeted development of breast cancer care in The Gambia: a cross-sectional study [2021]
• Germany
  • Archives of Gynecology and Obstetrics
    • Multidisciplinary breast centres in Germany: a review and update of quality assurance through benchmarking and certification [2012]
  • Breast Care
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2021 [2021]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021 [2021]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020 [2020]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019 [2019]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019 [2019]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2016 [2016]
    • AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2016 [2016]
  • Deutsches Ärzteblatt International
    • The Screening, Diagnosis, Treatment, and Follow-Up of Breast Cancer [2018]
  • Geburtshilfe und Frauenheilkunde
    • Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer [2018]
  • Institute for Quality and Efficiency in Health Care
    • Systematic Guideline Search and Appraisal, as Well as Extraction of Relevant Recommendations, for the DMP "Breast Cancer" [2014]
• High-income countries
  • International Journal of Environmental Research and Public Health
    • What Is the Evidence Globally for Culturally Safe Strategies to Improve Breast Cancer Outcomes for Indigenous Women in High Income Countries? A Systematic Review [2021]
• India
  • South Asian Journal of Cancer
    • Breast cancer: An overview of published Indian data [2016]
• International
  • Annals of Translational Medicine
    • A quality evaluation of the clinical practice guidelines on breast cancer using the RIGHT checklist [2021]
  • Breast Health Global Initiative
    • The role of dissemination and implementation science in global breast cancer control programs: Frameworks, methods, and examples [2020]
    • The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource-Stratified Phased Implementation: Methods and overview [2020]
    • Situational analysis of breast health care systems: Why context matters [2020]
  • Current Oncology
    • Clinical practice guidelines in breast cancer [2018]
  • Senologic International Society
    • Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society Survey [2021]
• Iran
  • Iranian Journal of Public Health
    • Psychological Consequences of Breast Cancer in Iran: A Meta-Analysis [2019]
    • The Economic Burden of Breast Cancer in Iran [2015]
• Ireland
  • Department of Health
    • Diagnosis, Staging and Treatment of Patients with Breast Cancer [2015]
• Japan
  • BMC Research Notes
    • Cost of illness of breast cancer in Japan: trends and future projections [2015]
  • Breast Cancer
    • Recommendations for the management of breast cancer patients during the COVID-19 pandemic from the Japan Breast Cancer Society [2021]
• Latin America
  • Cancer Reports
    • Recommendations for streamlining precision medicine in breast cancer care in Latin America [2021]
  • ecancermedicalscience
    • Management of non-invasive tumours, benign tumours and breast cancer during the COVID-19 pandemic: recommendations based on a Latin American survey [2020]
  • Globalization and Health
    • Breast cancer policy in Latin America: account of achievements and challenges in five countries [2016]
• Lithuania
  • Medicina
    • The cost of newly diagnosed breast cancer in Lithuania, 2011 [2015]
• Low and middle income countries
  • Oncologist
    • Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review [2021]
  • Systematic Reviews
    • Economic analyses of breast cancer control in low- and middle-income countries: a systematic review [2013]
• Mexico
  • ecancermedicalscience
    • Costs of breast cancer care in Mexico: analysis of two insurance coverage scenarios [2015]
• Middle East, North Africa
  • ecancermedicalscience
    • Do we need regional guidelines for breast cancer management in the MENA region? MENA Breast Cancer Guidelines project [2017]
• Netherlands
  • Breast
    • Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis [2021]
  • Journal of Hematology & Oncology
    • Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study [2021]
• New Zealand
  • Ministry of Health New Zealand
    • Management of Early Breast Cancer: Evidence-based Best Practice Guideline [2009]
  • PLoS ONE
    • Differences in Breast Cancer Survival between Public and Private Care in New Zealand: Which Factors Contribute? [2016]
• Republic of Korea
  • Cancer Research and Treatment
    • The Economic Burden of Breast Cancer in Korea from 2007-2010 [2015]
• South Africa
  • Journal of Oncology
    • Improving Breast Cancer Control via the Use of Community Health Workers in South Africa: A Critical Review [2011]
  • National Department of Health
    • Breast Cancer Control Policy [2017]
• Spain
  • International Journal of Environmental Research and Public Health
    • Breast Cancer Care Quality Indicators in Spain: A Systematic Review [2021]
• Sub-Saharan Africa
  • International Agency for Research on Cancer
    • Breast Cancer Outcomes in Sub-Saharan Africa [2021]
  • JCO Global Oncology
    • Assessment of Breast Cancer Management in Sub-Saharan Africa [2021]
• Uganda
  • African Health Sciences
    • Breast cancer guidelines for Uganda (2nd Edition 2008) [2008]
• United Kingdom
  • British Journal of Cancer
    • Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research [2015]
  • International Journal of Breast Cancer
    • A Nationwide Cross-Sectional Survey of UK Breast Surgeons' Views on the Management of Ductal Carcinoma In Situ [2015]
  • National Institute for Health and Care Excellence
    • Early and locally advanced breast cancer: diagnosis and management [2023]
    • Advanced breast cancer: diagnosis and treatment [2017]
    • Breast cancer [2016]
    • Breast cancer
  • Scottish Government
    • Breast cancer clinical quality performance indicators [2016]
• United States
  • American Cancer Society
    • Breast Cancer Facts & Figures 2019-2020 [2019]
  • American Society of Clinical Oncology
    • Breast Cancer
  • Centers for Disease Control and Prevention
    • Breast Cancer
  • JNCI Cancer Spectrum
    • Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS) [2018]
  • M.D. Anderson Cancer Center
    • Inflammatory Breast Cancer
    • Breast Cancer
  • National Comprehensive Cancer Network
    • Breast Cancer
  • Obstetrics & Gynecology
    • Executive Summary of the Early-Onset Breast Cancer Evidence Review Conference [2020]
  • OncoLink
    • Breast Cancer
• WHO
  • International Agency for Research on Cancer
    • Breast cancer
  • World Health Organization
    • Global breast cancer initiative implementation framework: assessing, strengthening and scaling up of services for the early detection and management of breast cancer [2023]
    • The Global Breast Cancer Initiative
    • Breast cancer: Fact sheet
• {Related topics}
  • Guidelines
    • Triple negative breast cancer
    • Sentinel lymph node biopsy
    • Menopause, hormone replacement therapy, breast cancer
    • Mammography
    • Gynecologic oncology
    • Familial breast cancer
    • Breast plastic surgery
    • Breast imaging
    • Breast cancer treatment
    • Breast cancer stem cells
    • Breast cancer screening
    • Breast cancer risk
    • Breast cancer prevention
    • Breast cancer markers
    • Breast cancer epidemiology
    • Breast cancer diagnosis
    • Breast cancer and pregnancy
    • Breast biopsy, breast pathology
    • Benign breast diseases

Breast cancer and pregnancy

• Canada
  • Current Oncology
    • Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature [2015]
• China
  • Breast Cancer Research and Treatment
    • Physicians’ attitudes towards reproduction in young patients with early breast cancer in China [2020]
  • Chinese Medical Journal
    • Clinical practice guidelines for pregnancy-associated breast cancer: Chinese society of breast surgery (CSBrS) practice guidelines 2021 [2021]
• International
  • BMC Cancer
    • Prognosis of pregnancy-associated breast cancer: a meta-analysis [2020]
• Republic of Korea
  • Cancer Research and Treatment
    • Outcomes of Pregnancy after Breast Cancer in Korean Women: A Large Cohort Study [2020]
  • Frontiers in Oncology
    • The Risk Factors, Incidence and Prognosis of Postpartum Breast Cancer: A Nationwide Study by the SMARTSHIP Group [2022]
  • Journal of Breast Cancer
    • Neoadjuvant Chemotherapy and Prognosis of Pregnancy-Associated Breast Cancer: A Time-Trends Study of the Korean Breast Cancer Registry Database [2018]
  • Oncologist
    • Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer [2019]
  • PLoS ONE
    • Pregnancy-Associated Risk Factors of Postpartum Breast Cancer in Korea: A Nationwide Health Insurance Database Study [2016]
• Taiwan
  • Oncologist
    • Mortality of Pregnancy Following Breast Cancer Diagnoses in Taiwanese Women [2020]
• Turkey
  • Turkish Journal of Surgery
    • Fertility and breast cancer: Recommendations of the 2019 Izmir Consensus Conference [2020]
• United States
  • Academy of Breastfeeding Medicine
    • ABM Clinical Protocol #34: Breast Cancer and Breastfeeding [2020]
  • Breast Cancer Research
    • Outcomes of children exposed in utero to chemotherapy for breast cancer [2014]
  • National Cancer Institute
    • Breast Cancer Treatment During Pregnancy (PDQ®)
• {Related topics}
  • Guidelines
    • Obstetrics, perinatology
    • Breast cancer

Breast cancer diagnosis

• Africa
  • JCO Global Oncology
    • Prevalence of Themes Linked to Delayed Presentation of Breast Cancer in Africa: A Meta-Analysis of Patient-Reported Studies [2020]
• Australia
  • Cancer Australia
    • Investigation of a new breast symptom - a guide for general practitioners [2021]
    • Summary of the development process and methodology for the investigation of a new breast symptom GP card [2017]
• Sub-Saharan Africa
  • Lancet Global Health
    • Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis [2016]
• United Kingdom
  • Association of Breast Surgery
    • Best practice diagnostic guidelines for patients presenting with breast symptoms [2010]
• United States
  • American College of Radiology
    • Stage I Breast Cancer: Initial Work up and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women
• {Related topics}
  • Guidelines
    • Mammography
    • Breast imaging
    • Breast cancer screening
    • Breast cancer
    • Breast biopsy, breast pathology

Breast cancer epidemiology

• Africa
  • African Health Sciences
    • Clustering time trends of breast cancer incidence in Africa: a 27-year longitudinal study in 53 countries [2021]
  • Journal of Global Health
    • Estimating the incidence of breast cancer in Africa: a systematic review and meta-analysis [2018]
• Algeria
  • Cancer Treatment and Research Communications
    • Epidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeria [2020]
• Arab countries
  • International Journal of Surgery
    • Age at diagnosis of breast cancer in Arab nations [2010]
• Asia
  • Breast Care
    • Current Status and Future Projections of Breast Cancer in Asia [2015]
  • Cancer
    • The Prevalence and Assessment of ErbB2-Positive Breast Cancer in Asia [2010]
  • Cancer Management and Research
    • Recent insights into breast cancer incidence trends among four Asian countries using age-period-cohort model [2019]
  • Journal of the National Cancer Institute
    • Female Breast Cancer Incidence Among Asian and Western Populations: More Similar Than Expected [2015]
  • Scientific Reports
    • Trends and Projections in Breast Cancer Mortality among four Asian countries (1990–2017): Evidence from five Stochastic Mortality Models [2020]
• Australia
  • BMC Cancer
    • A population-based study of breast cancer prevalence in Australia: predicting the future health care needs of women living with breast cancer [2014]
  • Cancer Australia
    • Report to the Nation - breast cancer 2012 [2012]
• Australia, Japan
  • Asian Pacific Journal of Cancer Prevention
    • Comparative Analysis of Breast Cancer Incidence Rates between Australia and Japan: Screening Target Implications [2020]
• Austria
  • Scientific Reports
    • Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983-2017) [2022]
• Bahamas
  • Breast Cancer : Basic and Clinical Research
    • Breast Cancer in the Bahamas in 2009–2011 [2016]
• Bahrain
  • Sultan Qaboos University Medical Journal
    • Epidemiology of Breast Cancer among Bahraini Women: Data from the Bahrain Cancer Registry [2014]
• Brazil
  • BMC Public Health
    • Temporal trends in female breast cancer mortality in Brazil and correlations with social inequalities: ecological time-series study [2015]
  • BMC Women's Health
    • The role of health policy in the burden of breast cancer in Brazil [2017]
  • Frontiers in Oncology
    • Breast Cancer Mortality in Young Women in Brazil [2021]
  • JCO Global Oncology
    • Epidemiological Analyses Reveal a High Incidence of Breast Cancer in Young Women in Brazil [2021]
  • Lancet Global Health
    • Ethnoracial and social trends in breast cancer staging at diagnosis in Brazil, 2001–14: a case only analysis [2019]
  • Revista da Associação Médica Brasileira
    • Female breast cancer mortality in Brazil and its regions [2014]
  • Scientific Reports
    • Effects of the high-inequality of income on the breast cancer mortality in Brazil [2019]
• Canada
  • Canadian Cancer Society
    • Breast cancer statistics
  • Canadian Journal of Public Health
    • The incidence of breast cancer in Canada 1971–2015: trends in screening-eligible and young-onset age groups [2020]
• Central African Republic
  • BMC Public Health
    • Epidemiology of breast cancer: retrospective study in the Central African Republic [2016]
• Central and South America
  • Cancer Epidemiology
    • Female breast cancer in Central and South America [2016]
• China
  • BMC Public Health
    • Historical trends in breast Cancer among women in China from age-period-cohort modeling of the 1990–2015 breast Cancer mortality data [2020]
  • Cancer Biology & Medicine
    • Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030 [2021]
  • Medicine
    • Epidemiological and Clinicopathological Trends of Breast Cancer in Chinese Patients During 1993 to 2013 [2015]
• Croatia
  • Oncologist
    • COVID-19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population- and Registry-Based Study [2021]
• Cyprus
  • Data in Brief
    • Epidemiology of breast cancer in Cyprus: Data on newly diagnosed cases and survival rates [2018]
• Denmark
  • International Journal of Cancer
    • Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark [2013]
  • International Journal of Epidemiology
    • Incidence of metachronous contralateral breast cancer in Denmark 1978–2009 [2014]
• East and South Asia
  • Frontiers in Nutrition
    • Breast Cancer Mortality Trends and Predictions to 2030 and Its Attributable Risk Factors in East and South Asian Countries [2022]
• East Asia
  • International Journal of Environmental Research and Public Health
    • Secular Trends of Breast Cancer in China, South Korea, Japan and the United States: Application of the Age-Period-Cohort Analysis [2015]
• Eastern Mediterranean
  • BMC Women's Health
    • Incidence trend of breast Cancer in women of eastern Mediterranean region countries from 1998 to 2019: A systematic review and meta-analysis [2020]
• Egypt
  • Journal of Thoracic Disease
    • Breast cancer in Egypt, China and Chinese: statistics and beyond [2014]
• Eritrea
  • International Journal of Breast Cancer
    • Incidence of Breast Cancer in Eritrea: A Retrospective Study from 2011 to 2017 [2019]
• Europe
  • Archives of Medical Science : AMS
    • Breast cancer mortality trends in Europe among women in perimenopausal and postmenopausal age (45+) [2020]
  • BMJ
    • Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database [2010]
  • Breast Care
    • Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries [2019]
  • European Journal of Cancer
    • European trends in breast cancer mortality, 1980–2017 and predictions to 2025 [2021]
  • European Journal of Public Health
    • Socioeconomic inequalities in breast cancer incidence and mortality in Europe—a systematic review and meta-analysis [2016]
  • JCO Global Oncology
    • Trends in Breast Cancer Mortality Between 2001 and 2017: An Observational Study in the European Union and the United Kingdom [2021]
• Germany
  • Deutsches Ärzteblatt International
    • Trends Over Time in Breast-Cancer-Specific Mortality in Germany [2021]
  • Geburtshilfe und Frauenheilkunde
    • Long-term Incidence and Mortality Trends for Breast Cancer in Germany [2020]
  • PLoS ONE
    • Incidence and Mortality Trends in German Women with Breast Cancer Using Age, Period and Cohort 1999 to 2008 [2016]
• Germany, United States
  • Cancers
    • Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States [2020]
• Ghana
  • International Journal of Breast Cancer
    • Pattern of Breast Cancer Distribution in Ghana: A Survey to Enhance Early Detection, Diagnosis, and Treatment [2016]
• Greenland
  • International Journal of Circumpolar Health
    • Breast cancer in the Arctic – changes over the past decades [2012]
• Hong Kong
  • British Journal of Cancer
    • Breast cancer incidence and mortality in a transitioning Chinese population: current and future trends [2014]
• Iceland
  • Scientific Reports
    • In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden [2020]
• India
  • Cancer Causes and Control
    • Symposium report: breast cancer in India—trends, environmental exposures and clinical implications [2021]
  • Indian Journal of Surgical Oncology
    • Time Trends in Breast Cancer Among Indian Women Population: An Analysis of Population Based Cancer Registry Data [2015]
• International
  • Aging
    • Global incidence and mortality of breast cancer: a trend analysis [2021]
  • Breast
    • Current and future burden of breast cancer: Global statistics for 2020 and 2040 [2022]
  • Cancer Communications
    • Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020 [2021]
  • Cancer Epidemiology Biomarkers & Prevention
    • International Variation in Female Breast Cancer Incidence and Mortality Rates [2015]
  • EClinicalMedicine
    • Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns [2021]
  • Frontiers in Oncology
    • The Global, Regional, and National Burden and Trends of Breast Cancer From 1990 to 2019: Results From the Global Burden of Disease Study 2019 [2021]
    • The Burden and Trends of Breast Cancer From 1990 to 2017 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2017 [2020]
  • Journal of Research in Medical Sciences
    • Worldwide trends in breast cancer incidence from 1993 to 2012: Age-period-cohort analysis and joinpoint regression [2020]
  • Lancet Global Health
    • Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study [2020]
  • Scientific Reports
    • Worldwide Age at Onset of Female Breast Cancer: A 25-Year Population-Based Cancer Registry Study [2019]
• Iran
  • Eastern Mediterranean Health Journal
    • Incidence pattern and spatial analysis of breast cancer in Iranian women: Geographical Information System applications [2018]
  • Frontiers in Oncology
    • National and Subnational Incidence, Mortality, and Years of Life Lost Due to Breast Cancer in Iran: Trends and Age-Period-Cohort Analysis Since 1990 [2021]
  • Iranian Journal of Public Health
    • Age at Diagnosis of Breast Cancer in Iran: A Systematic Review and Meta-Analysis [2021]
  • PLoS ONE
    • Geographical and socioeconomic inequalities in female breast cancer incidence and mortality in Iran: A Bayesian spatial analysis of registry data [2021]
• Iraq
  • Asian Pacific Journal of Cancer Prevention
    • Trends in Breast Cancer Incidence in Iraq During the Period 2000-2019 [2021]
• Jamaica
  • JCO Global Oncology
    • Breast Cancer in Jamaica: Trends From 2010 to 2014—Is Mortality Increasing? [2020]
• Kazakhstan
  • Asian Pacific Journal of Cancer Prevention
    • Impact of Screening on Breast Cancer Incidence in Kazakhstan: Results of Component Analysis [2021]
  • Iranian Journal of Public Health
    • Breast Cancer in Megapolises of Kazakhstan: Epidemiological Assessment of Incidence and Mortality [2019]
• Latin America
  • ecancermedicalscience
    • Locally advanced breast cancer in young women in Latin America [2019]
• Lebanon
  • Medicina
    • Breast Cancer Epidemiology among Lebanese Women: An 11-Year Analysis [2019]
• Mongolia
  • Cancer Causes and Control
    • Breast cancer incidence in Mongolia [2012]
• Netherlands
  • BMC Cancer
    • Burden of early, advanced and metastatic breast cancer in The Netherlands [2018]
  • European Journal of Public Health
    • Breast cancer diagnosis and death in the Netherlands: a changing burden [2014]
  • International Journal of Cancer
    • Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017 [2021]
• Peru
  • BMC Cancer
    • Breast cancer mortality trends in Peruvian women [2020]
• Poland
  • BMC Public Health
    • Trends of mortality due to breast cancer in Poland, 2000–2016 [2020]
  • Przeglad Menopauzalny = Menopause Review
    • Incidence of and mortality from breast cancer among women in Poland in the years 2001-2010 [2014]
• Republic of Korea
  • Cancer Research and Treatment
    • Age-Period-Cohort Analysis of Female Breast Cancer Mortality in Korea [2015]
  • International Journal for Equity in Health
    • Increased breast cancer mortality only in the lower education group: age-period-cohort effect in breast cancer mortality by educational level in South Korea, 1983-2012 [2017]
  • Journal of Breast Cancer
    • Breast Cancer Statistics in Korea, 2018 [2021]
    • Breast Cancer Statistics in Korea in 2017: Data from a Breast Cancer Registry [2020]
    • Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy [2018]
    • Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer Registry [2018]
    • The Basic Facts of Korean Breast Cancer in 2013: Results of a Nationwide Survey and Breast Cancer Registry Database [2016]
    • The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database [2015]
    • The Basic Facts of Korean Breast Cancer in 2011: Results of a Nationwide Survey and Breast Cancer Registry Database [2014]
• Saudi Arabia
  • Saudi Medical Journal
    • Recent incidence and descriptive epidemiological survey of breast cancer in Saudi Arabia [2015]
• Taiwan
  • Oncotarget
    • Epidemiology and survival outcome of breast cancer in a nationwide study [2017]
• Taiwan, United States
  • Cancer Medicine
    • Comparison of annual percentage change in breast cancer incidence rate between Taiwan and the United States—A smoothed Lexis diagram approach [2017]
• United Kingdom
  • Cancer Research UK
    • Breast cancer statistics
• United States
  • American Cancer Society
    • Breast cancer statistics, 2019 [2019]
    • Breast cancer statistics, 2017, racial disparity in mortality by state [2017]
    • Cancer statistics: Breast cancer in situ [2015]
    • Breast cancer statistics, 2015: Convergence of incidence rates between black and white women [2015]
    • Breast cancer statistics, 2013 [2013]
  • American Journal of Cancer Research
    • Changing trends and disparities in 5-year overall survival of women with invasive breast cancer in the United States, 1975-2015 [2021]
  • Breast Cancer Research
    • Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992–2016 [2021]
  • Cancer
    • United States Breast Cancer Mortality Trends in Young Women According to Race [2014]
  • Cancer Epidemiology Biomarkers & Prevention
    • Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States [2017]
  • Centers for Disease Control and Prevention
    • Trends in Breast Cancer Incidence, by Race, Ethnicity, and Age Among Women Aged >=20 Years — United States, 1999–2018 [2022]
    • Patterns and Trends in Age-Specific Black-White Differences in Breast Cancer Incidence and Mortality – United States, 1999–2014 [2016]
    • Vital Signs: Racial Disparities in Breast Cancer Severity — United States, 2005–2009 [2012]
  • International Journal of Environmental Research and Public Health
    • Modeling Geospatial Patterns of Late-Stage Diagnosis of Breast Cancer in the US [2017]
    • Geospatial Analysis of Inflammatory Breast Cancer and Associated Community Characteristics in the United States [2017]
    • Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United States [2017]
  • International Journal of Health Geographics
    • Geographic disparities in late stage breast cancer incidence: results from eight states in the United States [2015]
  • JAMA Network Open
    • Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015 [2020]
  • JNCI Cancer Spectrum
    • Breast Cancer Incidence Trends by Estrogen Receptor Status Among Asian American Ethnic Groups, 1990–2014 [2020]
    • Incidence and Survival Among Young Women With Stage I–III Breast Cancer: SEER 2000–2015 [2019]
  • Journal of the National Cancer Institute
    • Annual Report to the Nation on the Status of Cancer, 1975–2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State [2015]
  • National Cancer Institute
    • Female Breast Cancer
  • World Journal of Oncology
    • Breast Cancer Incidence and Behavior in Younger Patients: A Study From the Surveillance, Epidemiology and End Results Database [2020]
• Vietnam
  • Cancer Biology & Medicine
    • Female breast cancer in Vietnam: a comparison across Asian specific regions [2015]
• WHO
  • International Agency for Research on Cancer
    • Breast fact sheet
  • World Health Organization
    • Breast cancer
• {Related topics}
  • Guidelines
    • Breast cancer

Breast cancer markers

• Africa
  • PLoS Medicine
    • Receptor-Defined Subtypes of Breast Cancer in Indigenous Populations in Africa: A Systematic Review and Meta-Analysis [2014]
• Australia
  • Medical Services Advisory Committee
    • A 50 gene signature assay for predicting breast cancer recurrence [2021]
    • Gene expression profiling of 21 genes in breast cancer to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit [2013]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Oncotype DX in Women and Men with ER-Positive, HER2-Negative Early Stage Breast Cancer who are Lymph Node Negative: A Review of Clinical Effectiveness and Guidelines [2014]
    • Oncotype DX in Women and Men with ER-Positive HER2-Negative Early Stage Breast Cancer Who are Lymph Node-Positive: A Review of Clinical Effectiveness and Guidelines [2014]
  • Ontario Health
    • Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline [2022]
    • Gene Expression Profiling Tests for Early-Stage Invasive Breast Cancer: A Health Technology Assessment [2020]
• China
  • Cancer Epidemiology Biomarkers & Prevention
    • Cytochrome P450 1B1 and Catechol-O-Methyltransferase Genetic Polymorphisms and Breast Cancer Risk in Chinese Women: Results from the Shanghai Breast Cancer Study and a Meta-analysis [2005]
  • Chinese Medical Journal
    • Clinical practice guidelines for multigene assays in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
  • Scientific Reports
    • Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results [2019]
• Europe
  • European Commission
    • Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative [2021]
  • European Journal of Cancer
    • Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM) [2017]
• France
  • PLoS ONE
    • Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers [2017]
• Germany
  • Institute for Quality and Efficiency in Health Care
    • Biomarker-based tests for the decision for or against adjuvant systemic chemotherapy in primary breast cancer [2016]
• India
  • Indian Journal of Medical Research
    • Improving accuracy of breast cancer biomarker testing in India [2017]
  • South Asian Journal of Cancer
    • Practical consensus recommendations on management of HR + ve early breast cancer with specific reference to genomic profiling [2018]
• International
  • Cancer
    • Use of standard markers and incorporation of molecular markers into breast cancer therapy [2011]
  • International Ki67 in Breast Cancer Working Group
    • Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group [2021]
  • Seminars in Cancer Biology
    • Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer - ScienceDirect [2017]
• Ireland
  • Health Information and Quality Authority
    • A rapid HTA of gene expression profiling tests for guiding the use of adjuvant chemotherapy in early-stage invasive breast cancer [2023]
• Italy
  • Cancers
    • Definition of High-Risk Early Hormone-Positive HER2-Negative Breast Cancer: A Consensus Review [2022]
  • Oncotarget
    • Multigene tests for breast cancer: the physician’s perspective [2021]
• Latin America
  • JCO Global Oncology
    • Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin America [2021]
• Norway
  • Norwegian Institute of Public Health
    • Molecular tests for detection of PIK3CA mutations in men and postmenopausal women with HR+/HER2–, locally advanced or metastatic breast cancer [2022]
    • Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer [2019]
• Republic of Korea
  • Journal of Breast Cancer
    • Impact of the Updated Guidelines on Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer [2020]
• Rwanda
  • Bulletin of the World Health Organization
    • Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert® mRNA expression assay [2023]
• Singapore
  • Singapore Medical Journal
    • Concordance between core needle biopsy and surgical specimen for ER, PgR and Her2neu receptor status in breast cancer and study of difference in reliability between the two groups with the change in ASCO/CAP guidelines [2016]
• Spain
  • Sociedad Española de Oncología Médica
    • Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer [2021]
    • Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology [2018]
• Sweden
  • Cancers
    • Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based Study [2021]
• Switzerland
  • PLoS ONE
    • Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience [2015]
• United Kingdom
  • Breast Cancer Research and Treatment
    • The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience [2020]
  • British Journal of Cancer
    • Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data [2020]
  • National Institute for Health and Care Excellence
    • Magseed for locating impalpable breast cancer lesions [2020]
    • Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer [2018]
• United States
  • American Society of Clinical Oncology
    • Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update [2020]
    • Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update—Integration of Results From TAILORx [2019]
    • Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update [2018]
    • Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update [2017]
    • Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline [2016]
    • Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline [2015]
    • Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer
    • Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer
    • Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
    • Estrogen and Progesterone Receptor Testing in Breast Cancer
  • Breast Cancer Research and Treatment
    • Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis [2016]
  • Cancer Medicine
    • Surgeon and medical oncologist peer network effects on the uptake of the 21-gene breast cancer recurrence score assay [2021]
  • College of American Pathologists
    • Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American Pathologists [2019]
  • Genetics in Medicine
    • Recommendations from the EGAPP Working Group: does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer? [2016]
  • JAMA Network Open
    • Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016 [2020]
  • NPJ Breast Cancer
    • The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study [2021]
• {Related topics}
  • Guidelines
    • Breast cancer

Breast cancer prevention

• Australia
  • Preventing Chronic Disease: Public Health Research, Practice and Policy
    • Strategies for Piloting a Breast Health Promotion Program in the Chinese-Australian Population [2012]
• Europe
  • Nature Reviews Clinical Oncology
    • Personalized early detection and prevention of breast cancer: ENVISION consensus statement [2020]
• Hong Kong
  • Centre for Health Protection
    • Recommendations on Prevention and Screening for Breast Cancer For Health Professionals [2021]
• Spain
  • Sociedad Española de Oncología Médica
    • SEOM guide to primary and secondary prevention of cancer: 2014 [2014]
• United Kingdom
  • British Journal of General Practice
    • Prescribing tamoxifen in primary care for the prevention of breast cancer: a national online survey of GPs’ attitudes [2017]
  • Public Health Genomics
    • Clinician-Reported Barriers to Implementing Breast Cancer Chemoprevention in the UK: A Qualitative Investigation [2016]
• United States
  • Agency for Healthcare Research and Quality
    • Medication Use for the Risk Reduction of Primary Breast Cancer in Women: A Systematic Review for the U.S. Preventive Services Task Force  [2019]
  • American Society of Clinical Oncology
    • Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update [2019]
    • Use of Endocrine Therapy for Breast Cancer Risk Reduction
  • Breast Cancer Research and Treatment
    • The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family Registry [2015]
  • Journal of the National Cancer Institute
    • Practical Problems With Clinical Guidelines for Breast Cancer Prevention Based on Remaining Lifetime Risk [2015]
  • National Cancer Institute
    • Breast Cancer Prevention (PDQ®)
  • Preventing Chronic Disease: Public Health Research, Practice and Policy
    • Inclusion of Evidence-Based Breast Cancer Control Recommendations and Guidelines in State Comprehensive Cancer Control Plans [2020]
  • U.S. Preventive Services Task Force
    • Breast Cancer: Medication Use to Reduce Risk [2019]
• {Related topics}
  • Guidelines
    • Breast cancer

Breast cancer risk

• Asia
  • Asian Pacific Association for the Study of the Liver
    • A Review of the Epidemiology of Breast Cancer in Asia: Focus on Risk Factors [2020]
  • Heliyon
    • Assessment of the risk of developing breast cancer using the Gail model in Asian females: A systematic review [2020]
  • Journal of Preventive Medicine and Public Health
    • Breast Density and Risk of Breast Cancer in Asian Women: A Meta-analysis of Observational Studies [2016]
• Australia
  • Cancer Australia
    • Risk factors for breast cancer: A review of the evidence 2018 [2018]
    • Breast Cancer Risk Factors At a Glance [2018]
• Belarus
  • International Journal of Epidemiology
    • Breast cancer risk in residents of Belarus exposed to Chernobyl fallout while pregnant or lactating: standardized incidence ratio analysis, 1997 to 2016 [2022]
• Canada
  • Environment International
    • Associations between incident breast cancer and ambient concentrations of nitrogen dioxide from a national land use regression model in the Canadian National Breast Screening Study [2019]
  • International Journal of Breast Cancer
    • Adherence to cancer prevention guidelines and risk of breast cancer [2014]
• Caribbean
  • International Journal for Equity in Health
    • Social determinants of breast cancer in the Caribbean: a systematic review [2017]
• China
  • Chinese Journal of Cancer
    • Active and passive smoking with breast cancer risk for Chinese females: a systematic review and meta-analysis [2014]
  • Chinese Medical Journal
    • Clinical practice guidelines for risk assessment to identify women at high risk of breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
  • International Journal of Clinical and Experimental Medicine
    • GSTT1 polymorphism and breast cancer risk in the Chinese population: an updated meta-analysis and review [2015]
  • Journal of Breast Cancer
    • The Catechol-O-Methyltransferase Val158Met Polymorphism Contributes to the Risk of Breast Cancer in the Chinese Population: An Updated Meta-Analysis [2014]
  • Journal of Cancer Research and Therapeutics
    • Association between fibroblast growth factor receptor-2 gene polymorphism and risk of breast cancer in Chinese populations: A HuGE review and meta-analysis [2016]
  • Tumor Biology
    • Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case–control studies [2013]
• Denmark
  • Breast Cancer Research
    • Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study [2019]
• Europe
  • BMC Medicine
    • Dietary intake of trans fatty acids and breast cancer risk in 9 European countries [2021]
  • Cancer Epidemiology
    • European Code against Cancer 4th Edition: Breastfeeding and cancer [2015]
  • Environmental Health Perspectives
    • Long-Term Exposure to Ambient Air Pollution and Incidence of Postmenopausal Breast Cancer in 15 European Cohorts within the ESCAPE Project [2017]
• France
  • Environment International
    • Risk of breast cancer associated with long-term exposure to benzo[a]pyrene (BaP) air pollution: Evidence from the French E3N cohort study [2021]
• Gulf Cooperation Council
  • World Journal of Clinical Oncology
    • Correlation between breast cancer and lifestyle within the Gulf Cooperation Council countries: A systematic review [2020]
• International
  • Advances in Nutrition
    • Racial and Ethnic Disparities in the Impact of Obesity on Breast Cancer Risk and Survival: A Global Perspective [2015]
  • BMC Cancer
    • Global, regional, and national mortality trends of female breast cancer by risk factor, 1990–2017 [2021]
  • Breast Cancer : Targets and Therapy
    • Epidemiological characteristics of and risk factors for breast cancer in the world [2019]
  • Cancer
    • Fiber consumption and breast cancer incidence: A systematic review and meta-analysis of prospective studies [2020]
  • Cancers
    • Oral Contraceptive Use and Breast Cancer Risk According to Molecular Subtypes Status: A Systematic Review and Meta-Analysis of Case-Control Studies [2022]
    • Oral Contraceptive Use and Breast Cancer Risk Assessment: A Systematic Review and Meta-Analysis of Case-Control Studies, 2009–2020 [2021]
  • Environmental Research
    • Environmental exposures and breast cancer risk in the context of underlying susceptibility: A systematic review of the epidemiological literature [2020]
  • Frontiers in Oncology
    • Global Trends in Death, Years of Life Lost, and Years Lived With Disability Caused by Breast Cancer Attributable to Secondhand Smoke From 1990 to 2019 [2022]
  • International Journal of Environmental Research and Public Health
    • Use of Oral Contraceptives as a Potential Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis of Case-Control Studies Up to 2010 [2021]
    • Maternal Pregnancy Hormone Concentrations in Countries with Very Low and High Breast Cancer Risk [2020]
  • Journal of Clinical Oncology
    • Updated Breast Cancer Surveillance Recommendations for Female Survivors of Childhood, Adolescent, and Young Adult Cancer From the International Guideline Harmonization Group [2020]
  • Lancet Oncology
    • Recommendations for Breast Cancer Surveillance for Female Childhood, Adolescent and Young Adult Cancer Survivors Treated with Chest Radiation: A Report from the International Late Effects of Childhood Cancer Guideline Harmonization Group [2013]
• Iran
  • European Journal of Medical Research
    • Breast cancer risk factors in Iranian women: a systematic review and meta-analysis of matched case-control studies [2022]
  • International Journal of Preventive Medicine
    • Menstrual and Reproductive Factors and Risk of Breast Cancer in Iranian Female Population: A Systematic Review and Meta-Analysis [2022]
  • Iranian Journal of Basic Medical Sciences
    • Human papillomavirus and breast cancer in Iran: a meta- analysis [2016]
  • Journal of Cancer Prevention
    • The Role of Oral Contraceptive Pills on Increased Risk of Breast Cancer in Iranian Populations: A Meta-analysis [2016]
    • The Evaluation of p53 Polymorphism at Codon 72 and Association With Breast Cancer in Iran: A Systematic Review and Meta-analysis [2016]
• Italy
  • International Journal of Environmental Research and Public Health
    • Geographic Inequalities in Breast Cancer in Italy: Trend Analysis of Mortality and Risk Factors [2020]
• Japan
  • BMC Public Health
    • Association of job category and occupational activity with breast cancer incidence in Japanese female workers: the JACC study [2020]
  • Cancer Medicine
    • Impact of reproductive factors on breast cancer incidence: Pooled analysis of nine cohort studies in Japan [2021]
  • Japanese Journal of Clinical Oncology
    • Soy Intake and Breast Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiologic Evidence Among the Japanese Population [2014]
    • Breastfeeding and Breast Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiologic Evidence Among the Japanese Population [2012]
• Latin America
  • Genes
    • Genetic Epidemiology of Breast Cancer in Latin America [2019]
• Mongolia
  • PLoS ONE
    • The Role of Hormones in the Differences in the Incidence of Breast Cancer between Mongolia and the United Kingdom [2014]
• Netherlands
  • Breast Cancer Research and Treatment
    • The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors [2015]
  • Cancer Medicine
    • Risk of breast cancer in women after a salivary gland carcinoma or pleomorphic adenoma in the Netherlands [2020]
  • Oncologist
    • Evaluating the Age-Based Recommendations for Long-Term Follow-Up in Breast Cancer [2020]
• Norway
  • British Journal of Cancer
    • The fraction of breast cancer attributable to smoking: The Norwegian women and cancer study 1991–2012 [2016]
• Qatar
  • Journal of Primary Care & Community Health
    • Assessing Breast Cancer Risk Estimates Based on the Gail Model and Its Predictors in Qatari Women [2017]
• Republic of Korea
  • Scientific Reports
    • Impact of air pollution on breast cancer incidence and mortality: a nationwide analysis in South Korea [2020]
• Singapore
  • Scientific Reports
    • Incidence of breast cancer attributable to breast density, modifiable and non-modifiable breast cancer risk factors in Singapore [2020]
• Spain
  • BMC Cancer
    • An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain [2013]
  • Scientific Reports
    • Validating a breast cancer score in Spanish women. The MCC-Spain study [2018]
• Sweden
  • Breast Cancer Research and Treatment
    • Drug use disorder and risk of incident and fatal breast cancer: a nationwide epidemiological study [2021]
  • Fertility and Sterility
    • Ovarian stimulation and risk of breast cancer in Swedish women [2017]
• Switzerland
  • Gland Surgery
    • The impact of overweight and obesity on breast cancer: data from Switzerland, so far a country little affected by the current global obesity epidemic [2014]
• Taiwan
  • BMJ Open
    • Thyroid disorders and breast cancer risk in Asian population: a nationwide population-based case–control study in Taiwan [2018]
  • International Journal of Obesity
    • Body mass index and breast cancer: analysis of a nation-wide population-based prospective cohort study on 1 393 985 Taiwanese women [2015]
  • Scientific Reports
    • Reproductive and environmental exposures and the breast cancer risk in Taiwanese women [2021]
• United Kingdom
  • British Journal of Cancer
    • Ethnic differences in breast cancer incidence in England are due to differences in known risk factors for the disease: prospective study [2013]
  • Cancer Medicine
    • Thyroid dysfunction and breast cancer risk among women in the UK Biobank cohort [2021]
  • Faculty of Sexual & Reproductive Healthcare
    • Response to Study Contemporary Hormonal Contraception and the Risk of Breast Cancer [2017]
  • JAMA Network Open
    • Association of Nongenetic Factors With Breast Cancer Risk in Genetically Predisposed Groups of Women in the UK Biobank Cohort [2020]
• United States
  • American Cancer Society
    • Challenges in DCIS Risk Communication and Decision-Making: Report from an American Cancer Society and National Cancer Institute Workshop [2012]
  • Applied Geography
    • Identifying county-level factors for female breast cancer incidence rate through a large-scale population study [2020]
  • Breast Cancer Surveillance Consortium
    • Association between air pollution and mammographic breast density in the Breast Cancer Surveilance Consortium [2017]
  • Cancer
    • Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women’s Health Initiative [2020]
    • A review of body size and breast cancer risk in Hispanic and African American women [2011]
  • Frontiers in Public Health
    • Race, Age, and Obesity Disparities in Adult Physical Activity Levels in Breast Cancer Patients And Controls [2014]
  • JAMA Network Open
    • Trends in Parity and Breast Cancer Incidence in US Women Younger Than 40 Years From 1935 to 2015 [2020]
  • JAMA Oncology
    • Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States [2016]
  • Molecular and Cellular Endocrinology
    • US EPA's regulatory pesticide evaluations need clearer guidelines for considering mammary gland tumors and other mammary gland effects [2020]
  • National Cancer Institute
    • Postpartum Remodeling, Lactation, and Breast Cancer Risk: Summary of a National Cancer Institute–Sponsored Workshop [2013]
    • Breast Cancer Risk Assessment Tool
  • National Comprehensive Cancer Network
    • Breast Cancer Risk Reduction, Version 2.2015 [2015]
• {Related topics}
  • Guidelines
    • Familial breast cancer
    • Breast cancer

Breast cancer screening

• Albania
  • Institute of Public Health
    • Breast Cancer Screening in Albania During 2007-2008 [2013]
• Asia
  • Hong Kong Medical Journal
    • Understanding breast cancer screening—past, present, and future [2018]
• Australia
  • Australian Institute of Health and Welfare
    • BreastScreen Australia monitoring report 2020 [2020]
    • BreastScreen Australia data dictionary: version 1.2 [2019]
    • Analysis of breast cancer outcomes and screening behaviour for BreastScreen Australia [2018]
  • Cancer Australia
    • Early detection of breast cancer [2015]
  • Department of Health and Aged Care
    • BreastScreen Australia accreditation
  • Public Health Research and Practice
    • Public health advocacy in action: the case of unproven breast cancer screening in Australia [2016]
• Brazil
  • Cadernos de Saúde Pública
    • Guidelines for early detection of breast cancer in Brazil. III - Challenges for implementation [2018]
    • Guidelines for early detection of breast cancer in Brazil. II - New national recommendations, main evidence, and controversies [2018]
    • Guidelines for early detection of breast cancer in Brazil. I - Development methods [2018]
  • Epidemiologia e Serviços de Saúde
    • Assessment of actions for breast cancer early detection in Brazil using process indicators: a descriptive study with Sismama data, 2010-2011 [2017]
  • Revista Brasileira de Ginecologia e Obstetrícia
    • Breast Cancer Screening: Updated Recommendations of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Breast Disease Society, and Brazilian Federation of Gynecological and Obstetrical Associations [2017]
• Canada
  • Canadian Task Force on Preventive Health Care
    • Breast Cancer Update (2018) [2018]
  • CMAJ
    • Applying the 2011 Canadian guidelines for breast cancer screening in practice [2012]
  • Current Oncology
    • Screening for breast cancer in 2018—what should we be doing today? [2018]
    • Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies [2016]
  • Ontario Health
    • Breast Screening for Survivors of Breast Cancer [2017]
    • Women's Experiences of Inaccurate Breast Cancer Screening Results: A Systematic Review and Qualitative Meta-synthesis [2016]
    • Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment [2016]
    • Magnetic Resonance Imaging as an Adjunct to Mammography for Breast Cancer Screening in Women at Less Than High Risk for Breast Cancer: A Health Technology Assessment [2016]
• China
  • Cancer Biology & Medicine
    • Interpretation of breast cancer screening guideline for Chinese women [2019]
  • China CDC Weekly
    • Breast Cancer Screening Rates Among Women Aged 20 Years and Above — China, 2015 [2021]
  • Oncologist
    • Breast Cancer Challenges and Screening in China: Lessons From Current Registry Data and Population Screening Studies [2015]
  • Preventing Chronic Disease: Public Health Research, Practice and Policy
    • Breast Cancer Screening Among Adult Women in China, 2010 [2013]
• Czech Republic
  • BMC Public Health
    • Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme [2011]
• Democratic Republic of Congo
  • BMC Public Health
    • From the set-up of a screening program of breast cancer patients to the identification of the first BRCA mutation in the DR Congo [2014]
• Denmark
  • International Journal of Cancer
    • Benefit-to-harm ratio of the Danish breast cancer screening programme [2017]
• Developing countries
  • Clinics
    • Breast cancer screening in developing countries [2017]
• Eastern Mediterranean
  • WHO Regional Office for the Eastern Mediterranean
    • Guidelines for the early detection and screening of breast cancer [2006]
• Ethiopia
  • PLoS ONE
    • Breast self-examination practice and its determinants among women in Ethiopia: A systematic review and meta-analysis [2021]
• Europe
  • Cancers
    • Extending Age Ranges in Breast Cancer Screening in Four European Countries: Model Estimations of Harm-to-Benefit Ratios [2021]
  • European Commission
    • Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators [2020]
    • Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines [2020]
    • European guidelines on breast cancer screening and diagnosis
  • European Menopause and Andropause Society
    • EMAS position statement: Individualized breast cancer screening versus population-based mammography screening programmes [2014]
  • European Society of Breast Imaging
    • Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies [2017]
  • International Journal of Cancer
    • The potential of breast cancer screening in Europe [2021]
  • International Journal of Oncology
    • Breast cancer in European Union: An update of screening programmes as of March 2014 (Review) [2014]
• France
  • BMC Medical Ethics
    • Women's participation in breast cancer screening in France - an ethical approach [2014]
• Germany
  • Cancer Prevention Research
    • Estimating the Breast Cancer Burden in Germany and Implications for Risk-based Screening [2021]
• Ghana
  • BMC Health Services Research
    • Mapping evidence on knowledge of breast cancer screening and its uptake among women in Ghana: a scoping review [2022]
  • Heliyon
    • The prevalence and predictive factors of breast cancer screening among older Ghanaian women [2020]
• Greenland
  • International Journal of Circumpolar Health
    • Societal costs and effects of implementing population-based mammography screening in Greenland [2017]
• Hong Kong
  • Hong Kong Medical Journal
    • Update on the Recommendations on Breast Cancer Screening by the Cancer Expert Working Group on Cancer Prevention and Screening [2022]
• India
  • Journal of Cancer Research and Therapeutics
    • Knowledge, attitude, and practice towards breast cancer and its screening among women in India: A systematic review [2021]
• International
  • Breast Health Global Initiative
    • Breast cancer early detection: A phased approach to implementation [2020]
  • Cancer Medicine
    • Systematic reviews as a “lens of evidence”: Determinants of cost-effectiveness of breast cancer screening [2019]
  • Global Health Action
    • The global role, impact, and limitations of Community Health Workers (CHWs) in breast cancer screening: a scoping review and recommendations to promote health equity for all [2021]
  • Journal of the American Board of Family Medicine
    • Breast Cancer Screening in Older Women: the importance of shared decision making [2020]
• Iran
  • Journal of Research in Medical Sciences
    • Status of breast cancer screening strategies and indicators in Iran: A scoping review [2022]
• Ireland
  • Health Information and Quality Authority
    • Review of information management practices at BreastCheck [2018]
• Japan
  • Asian Pacific Journal of Cancer Prevention
    • Analysis of Predictors of Breast Cancer Screening among Japanese Women Using Nationally Representative Survey Data, 2001–2013 [2021]
  • Breast Cancer
    • The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition [2020]
  • Japanese Journal of Clinical Oncology
    • The Japanese Guidelines for Breast Cancer Screening [2016]
• Low and middle income countries
  • Indian Journal of Medical Research
    • Screening for breast cancer: Cost-effective solutions for low- & middle-income countries [2021]
• Malaysia
  • Asian Pacific Journal of Cancer Prevention
    • Breast Cancer Screening in Malaysia: A Policy Review [2021]
• New Zealand
  • Ministry of Health New Zealand
    • Cohort and case control analyses of breast cancer mortality: BreastScreen Aotearoa 1999-2011 [2015]
    • BreastScreen Aotearoa National Policy and Quality Standards [2013]
  • National Screening Unit
    • BreastScreen Aotearoa
• Norway
  • European Journal of Public Health
    • Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway [2014]
  • International Journal of Cancer
    • Cost-effectiveness of the Norwegian breast cancer screening program [2017]
• Peru
  • PLoS ONE
    • Cost-Effectiveness Analysis of Breast Cancer Control Interventions in Peru [2013]
• Qatar
  • BMJ Open
    • Do socioeconomic factors influence breast cancer screening practices among Arab women in Qatar? [2015]
• Singapore
  • Singapore Medical Journal
    • The Case for Breast Cancer Screening in Singapore [2002]
• Sub-Saharan Africa
  • BMC Cancer
    • Breast cancer screening in sub-Saharan Africa: a systematic review and ethical appraisal [2022]
  • BMJ Open
    • Prevalence and determinants of breast cancer screening in four sub-Saharan African countries: a population-based study [2020]
• Switzerland
  • BMC Health Services Research
    • Breast cancer screening attendance in two Swiss regions dominated by opportunistic or organized screening [2016]
• Tunisia
  • Health Research Policy and Systems
    • Contextual differences considered in the Tunisian ADOLOPMENT of the European guidelines on breast cancer screening [2021]
• United Kingdom
  • BMC Cancer
    • Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders’ views on a low-risk breast screening pathway [2020]
  • British Journal of Cancer
    • Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study [2016]
    • The benefits and harms of breast cancer screening: an independent review [2013]
  • Healthcare Improvement Scotland
    • Review of the Scottish Breast Screening Programme: December 2016 [2016]
    • Breast screening standards
  • NHS Digital
    • Breast Screening Programme
  • NHS England
    • NHS Breast screening programme screening standards valid for data collected from 1 April 2021
    • NHS Breast screening programme screening standards valid for data collected from 1 April 2017
    • Breast screening: very high risk women surveillance protocols
    • Breast screening: professional guidance
    • Breast screening supporting information
    • Breast screening programme: standards
  • Office for Health Improvement and Disparities
    • Breast screening pathway requirements specification
  • Public Health England
    • Opting out of breast screening
    • NHS breast screening (BSP) programme
    • Breast screening: programme overview
    • Breast screening: organising very high risk (VHR) screening
    • Breast screening: interval cancers and duty of candour toolkit
    • Breast screening: interval cancers
    • Breast screening: care pathway
  • Public Health Scotland
    • Scottish breast screening programme statistics
  • Public Health Wales
    • Breast screening
• United States
  • Agency for Healthcare Research and Quality
    • Supplemental Screening for Breast Cancer in Women With Dense Breasts [2016]
    • Screening for Breast Cancer: A Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation [2016]
  • American Cancer Society
    • Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society [2015]
    • Breast Cancer Screening Guidelines
  • American College of Physicians
    • Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians [2019]
  • American College of Radiology
    • Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR [2018]
    • Breast Cancer Screening
  • Breast Cancer Research and Treatment
    • Breast Cancer Screening in the Era of Density Notification Legislation: Summary of 2014 Massachusetts Experience and Suggestion of An Evidence-Based Management Algorithm by Multi-disciplinary Expert Panel [2015]
  • Journal of General Internal Medicine
    • Guideline-Inconsistent Breast Cancer Screening for Women over 50: A Vignette-Based Survey [2014]
  • National Cancer Institute
    • Breast Cancer Screening (PDQ®)
  • U.S. Preventive Services Task Force
    • Breast Cancer: Screening [2016]
• WHO
  • International Agency for Research on Cancer
    • Atlas of breast cancer early detection [2023]
    • Breast Cancer Screening [2016]
    • Breast-Cancer Screening — Viewpoint of the IARC Working Group [2015]
    • Breast self-examination (BSE)
• {Related topics}
  • Guidelines
    • Mammography
    • Breast imaging
    • Breast cancer diagnosis
    • Breast cancer

Breast cancer stem cells

• International
  • Cells
    • Preclinical and Clinical Trials of New Treatment Strategies Targeting Cancer Stem Cells in Subtypes of Breast Cancer [2023]
• United States
  • Scientific Reports
    • Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity [2013]
• {Related topics}
  • Guidelines
    • Breast cancer

Breast cancer treatment

• Arab countries
  • Health and Quality of Life Outcomes
    • Quality of life in Arab women with breast cancer: a review of the literature [2016]
• Asia
  • BMJ Open
    • Health-related quality of life in Asian patients with breast cancer: a systematic review [2018]
  • Journal of Breast Cancer
    • Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide [2016]
  • PLoS ONE
    • Predicting Survival of De Novo Metastatic Breast Cancer in Asian Women: Systematic Review and Validation Study [2014]
• Australia
  • Australian Journal of General Practice
    • Update on the management of early-stage breast cancer [2019]
    • Advanced breast cancer [2019]
  • Cancer Australia
    • Guidance for the management of early breast cancer: Recommendations and practice points [2020]
    • Guidance for the management of early breast cancer: Methods [2020]
    • Recommendations for follow-up of women with early breast cancer [2010]
  • Journal of Comorbidity
    • Incidence of Comorbidities in Women with Breast Cancer Treated with Tamoxifen or an Aromatase Inhibitor: An Australian Population-Based Cohort Study [2018]
  • PLoS ONE
    • Women Commencing Anastrozole, Letrozole or Tamoxifen for Early Breast Cancer: The Impact of Comorbidity and Demographics on Initial Choice [2014]
• Austria
  • SpringerPlus
    • Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria [2015]
• Brazil
  • International Journal of Environmental Research and Public Health
    • Waiting Time between Breast Cancer Diagnosis and Treatment in Brazilian Women: An Analysis of Cases from 1998 to 2012 [2020]
• Canada
  • Breast Cancer Research and Treatment
    • A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles [2022]
  • Canadian Agency for Drugs and Technologies in Health
    • Regional Chemotherapy for the Treatment of Breast Cancer: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines [2018]
  • Canadian Family Physician
    • Breast Cancer Survivorship Tool [2020]
    • Follow-up after treatment for breast cancer: Practical guide to survivorship care for family physicians [2016]
  • Current Oncology
    • Systemic treatment approaches in her2-negative advanced breast cancer—guidance on the guidelines [2015]
    • Optimal systemic therapy for early breast cancer in women: a clinical practice guideline [2015]
    • Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor–positive metastatic breast cancer in Canada [2013]
  • Ontario Health
    • Systemic targeted therapy for her2-positive early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline [2015]
    • Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline [2015]
    • Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline [2015]
    • Cancer Care Ontario’s Position Statement on Guidelines for Breast Cancer Well Follow-Up Care [2012]
• Canada, United States
  • CA: A Cancer Journal for Clinicians
    • Clinical practice guidelines on the evidence-based use of integrative therapies during and following breast cancer treatment [2017]
• China
  • Annals of Translational Medicine
    • Chemotherapy or endocrine therapy, first-line treatment for patients with hormone receptor-positive HER2-negative metastatic breast cancer in China: a real-world study [2021]
  • Chinese Medical Journal
    • Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021 [2021]
  • Frontiers in Oncology
    • Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China [2021]
  • Journal of Oncology
    • Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China [2021]
  • Oncotarget
    • A nation-wide multicenter 10-year (1999–2008) retrospective study of chemotherapy in Chinese breast cancer patients [2017]
• Europe
  • BMC Cancer
    • Patterns of resource utilization and cost for postmenopausal women with hormone-receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer in Europe [2015]
  • BMC Health Services Research
    • Adherence to breast cancer guidelines is associated with better survival outcomes: a systematic review and meta-analysis of observational studies in EU countries [2020]
  • Clinical Breast Cancer
    • A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer [2017]
  • European Society for Medical Oncology
    • Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies [2020]
• Europe, United States
  • Cancers
    • FDA and EMA Approvals of New Breast Cancer Drugs—A Comparative Regulatory Analysis [2020]
• Germany
  • BMC Cancer
    • The adherence paradox: guideline deviations contribute to the increased 5-year survival of breast cancer patients [2015]
  • Breast Cancer
    • Adjuvant chemotherapeutic treatment of 1650 patients with early breast cancer in routine care in Germany: data from the prospective TMK cohort study [2018]
  • Breast Care
    • International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus - Assessment by a German Group of Experts [2020]
    • Treatment of Early Breast Cancer Patients: Evidence, Controversies, Consensus: Focusing on Systemic Therapy – German Experts' Opinions for the 16th International St. Gallen Consensus Conference (Vienna 2019) [2019]
    • ABC4 Consensus: Assessment by a German Group of Experts [2018]
    • ABC3 Consensus: Assessment by a German Group of Experts [2016]
    • 14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus – Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts [2015]
    • Guideline Conformity Treatment in Young Women with Early-Onset Breast Cancer in Germany [2014]
    • 13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus – Opinion of a German Team of Experts (Zurich 2013) [2013]
  • Geburtshilfe und Frauenheilkunde
    • Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus Conference [2021]
    • AGO Algorithms for the Treatment of Breast Cancer: Update 2021 [2021]
    • ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019: Commentary by the German panel of experts on the ABC5 voting results [2020]
    • Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer [2018]
    • 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts [2018]
    • Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus [2017]
    • ABC3 Consensus Commented from the Perspective of the German Guidelines [2016]
    • Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015) [2015]
  • Institute for Quality and Efficiency in Health Care
    • Palbociclib (breast cancer) - Benefit assessment according to §35a Social Code Book V [2017]
  • International Journal of Cancer
    • Time trends of neoadjuvant chemotherapy for early breast cancer [2020]
• Greece
  • BMC Health Services Research
    • Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study [2015]
• India
  • Indian Journal of Medical Research
    • Consensus on contentious issues relevant for breast cancer management for the Indian scenario: Statements following a multicentre expert group meeting [2021]
    • Breast cancer survivorship in India [2021]
  • Indian Journal of Surgery
    • Indian Solutions for Indian Problems—Association of Breast Surgeons of India (ABSI) Practical Consensus Statement, Recommendations, and Guidelines for the Treatment of Breast Cancer in India [2017]
  • Journal of Cancer Research and Therapeutics
    • Patient-reported quality of life outcomes in Indian breast cancer patients: Importance, review of the researches, determinants and future directions [2013]
  • South Asian Journal of Cancer
    • Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India [2021]
• International
  • Annals of Oncology
    • Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 [2015]
  • BMJ Open
    • Evidence-based recommendations on care for breast cancer survivors for primary care providers: a review of evidence-based breast cancer guidelines [2017]
  • Breast
    • Quality and reporting of clinical guidelines for breast cancer treatment: A systematic review [2020]
  • Breast Care
    • St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer [2021]
    • St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment [2019]
  • Breast Health Global Initiative
    • Breast cancer treatment: A phased approach to implementation [2020]
  • Cancer Treatment Reviews
    • Risk-based decision-making in the treatment of HER2-positive early breast cancer: Recommendations based on the current state of knowledge [2021]
  • European Society for Medical Oncology
    • 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) [2020]
    • 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4) [2018]
    • 3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3) [2017]
  • Geburtshilfe und Frauenheilkunde
    • Update Breast Cancer 2021 Part 3 – Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert Panel [2021]
  • Health Expectations
    • Shared decision making in breast cancer treatment guidelines: Development of a quality assessment tool and a systematic review [2020]
  • JCO Global Oncology
    • Are NCCN Resource-Stratified Guidelines for Breast Cancer Systemic Therapy Achievable? A Population-Based Study of Global Need and Economic Impact [2021]
  • Journal of Cancer Survivorship
    • Strategies to self-manage side-effects of adjuvant endocrine therapy among breast cancer survivors: an umbrella review of empirical evidence and clinical guidelines [2021]
  • Journal of the National Cancer Institute
    • International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured? [2010]
    • International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy [2009]
  • NPJ Breast Cancer
    • Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic [2020]
  • Oncotarget
    • Role of cooperative groups and funding source in clinical trials supporting guidelines for systemic therapy of breast cancer [2018]
  • PLoS ONE
    • Global treatment costs of breast cancer by stage: A systematic review [2018]
• Ireland, Netherlands
  • PLoS ONE
    • Treatment Strategies and Survival of Older Breast Cancer Patients – An International Comparison between the Netherlands and Ireland [2015]
• Italy
  • BMC Cancer
    • An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project [2018]
  • Breast
    • Influence of adherence with guideline-driven recommendations on survival in women operated for breast cancer: Real-life evidence from Italy [2020]
• Japan
  • Breast Cancer
    • The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition [2020]
    • Evidence produced in Japan: tegafur-based preparations for postoperative chemotherapy in breast cancer [2013]
  • Japanese Journal of Clinical Oncology
    • The Transition of Breast Cancer Treatment and Japan Clinical Oncology Group Research Over Two Decades [2012]
• Latin America and the Caribbean
  • Oncologist
    • Health-Related Quality of Life in Patients with Breast Cancer in Latin America and the Caribbean: A Systematic Review and Meta-Analysis [2021]
• Low and middle income countries
  • BMC Cancer
    • Essential medicines for breast cancer in low and middle income countries [2015]
  • Breast Health Global Initiative
    • Supportive care during treatment for breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement [2013]
    • Supportive care after curative treatment for breast cancer (survivorship care): Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement [2013]
• Morocco
  • Breast Journal
    • Management of breast cancer during COVID-19 pandemic in Morocco [2020]
• Netherlands
  • BMC Cancer
    • Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive/HER2-negative breast cancers in The Netherlands [2016]
  • Breast Cancer Research and Treatment
    • The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients [2021]
    • The association of socioeconomic status on treatment strategy in patients with stage I and II breast cancer in the Netherlands [2021]
• New Zealand
  • Breast
    • New Zealand experience with implementation of the ESO-ESMO consensus guidelines for advanced breast cancer-report of achievements and lessons learned [2022]
  • International Journal of Environmental Research and Public Health
    • Use of Non-Cancer Medications in New Zealand Women at the Diagnosis of Primary Invasive Breast Cancer: Prevalence, Associated Factors and Effects on Survival [2020]
• Nigeria
  • ecancermedicalscience
    • Assessment of guideline adherence in breast cancer management among oncologists in Nigeria [2021]
• Norway
  • Breast Cancer Research and Treatment
    • Stage-specific survival has improved for young breast cancer patients since 2000: but not equally [2020]
• Republic of Korea
  • Annals of Surgical Treatment and Research
    • The reality in the follow-up of breast cancer survivors: survey of Korean Breast Cancer Society [2015]
  • ClinicoEconomics and Outcomes Research
    • Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea [2016]
  • Journal of Breast Cancer
    • Differences in Clinical Outcomes between Luminal A and B Type Breast Cancers according to the St. Gallen Consensus 2013 [2015]
    • Meeting Highlights: The First Korean Breast Cancer Treatment Consensus Conference [2014]
  • Journal of Korean Medical Science
    • Nationwide Analysis of Treatment Patterns for Korean Breast Cancer Survivors Using National Health Insurance Service Data [2018]
  • Nutrients
    • Adherence to Guidelines for Cancer Survivors and Health-Related Quality of Life among Korean Breast Cancer Survivors [2015]
• Serbia
  • JBUON
    • Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE [2018]
• Singapore
  • Scientific Reports
    • Impact of deviation from guideline recommended treatment on breast cancer survival in Asia [2020]
• Spain
  • Clinical and Translational Oncology
    • Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC) [2018]
    • Defining the optimal sequence for the systemic treatment of metastatic breast cancer [2016]
  • Health and Quality of Life Outcomes
    • Health-related quality of life in Spanish breast cancer patients: a systematic review [2011]
  • Journal of Drug Assessment
    • Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists [2019]
  • Oncologist
    • GEICAM Guidelines for the Management of Patients with Breast Cancer During Spain's COVID-19 Pandemic [2020]
  • Scientific Reports
    • Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study [2021]
  • Sociedad Española de Oncología Médica
    • SEOM clinical guidelines in early stage breast cancer (2018) [2019]
    • SEOM clinical guidelines in advanced and recurrent breast cancer (2018) [2019]
    • Recommendations for the follow-up care of female breast cancer survivors: a guideline of the Spanish Society of Medical Oncology (SEOM), Spanish Society of General Medicine (SEMERGEN), Spanish Society for Family and Community Medicine (SEMFYC), Spanish Society for General and Family Physicians (SEMG), Spanish Society of Obstetrics and Gynecology (SEGO), Spanish Society of Radiation Oncology (SEOR), Spanish Society of Senology and Breast Pathology (SESPM), and Spanish Society of Cardiology (SEC) [2018]
    • SEOM clinical guidelines in metastatic breast cancer 2015 [2015]
• Sub-Saharan Africa
  • Breast Cancer Research
    • Inequities in breast cancer treatment in sub-Saharan Africa: findings from a prospective multi-country observational study [2019]
• Switzerland
  • Cancers
    • Management and Outcome of Young Women (=40 Years) with Breast Cancer in Switzerland [2022]
• Taiwan
  • Breast
    • Effectiveness and healthcare costs of eribulin versus capecitabine among metastatic breast cancer patients in Taiwan [2021]
  • Scientific Reports
    • Health Services Utilisation in Breast Cancer Survivors in Taiwan [2014]
• Turkey
  • Turkish Journal of Surgery
    • Turkish national consensus on breast cancer management during temporary state of emergency due to COVID-19 outbreak [2020]
• United Kingdom
  • Association of Breast Surgery
    • Endocrine Treatment for Breast Cancer [2021]
  • BMJ Open
    • Societal costs of chemotherapy in the UK: an incidence-based cost-of-illness model for early breast cancer [2021]
  • British Journal of Cancer
    • Breast cancer management pathways during the COVID-19 pandemic: outcomes from the UK ‘Alert Level 4’ phase of the B-MaP-C study [2021]
  • Cancer Biology & Medicine
    • The decision-making process for senior cancer patients: treatment allocation of older women with operable breast cancer in the UK [2015]
  • Healthcare Improvement Scotland
    • External assurance of performance against Breast Cancer QPIs - National review report: December 2016 [2016]
    • Breast Cancer Clinical Quality Performance Indicators [2016]
  • Indian Journal of Surgery
    • Breast Cancer Management Guidelines During COVID-19 Pandemic [2020]
  • National Institute for Health and Care Excellence
    • Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapy [2023]
    • Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies [2022]
    • Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy [2022]
    • Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer [2022]
    • Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence [2022]
    • Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy [2021]
    • Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy [2021]
    • Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer [2019]
    • Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen [2018]
    • Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer [2017]
    • Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer [2017]
    • Everolimus with exemestane for treating advanced breast cancer after endocrine therapy [2016]
    • Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens [2016]
    • Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2 [2012]
    • Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer [2006]
• United States
  • American Cancer Society
    • American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline [2015]
  • American College of Radiology
    • Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer
    • Locally Advanced Breast Cancer
  • American Society of Breast Surgeons
    • Analysis of the Impact of the COVID-19 Pandemic on the Multidisciplinary Management of Breast Cancer: Review from the American Society of Breast Surgeons COVID-19 and Mastery Registries [2021]
  • American Society of Clinical Oncology
    • Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline [2021]
    • Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Update [2021]
    • Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Update [2021]
    • Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update [2020]
    • Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline [2019]
    • Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Clinical Practice Guideline Update [2018]
    • Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update [2018]
    • Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update [2018]
    • Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline [2018]
    • Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update [2018]
    • Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update [2017]
    • Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) –Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline [2016]
    • Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression [2016]
    • Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update [2013]
    • Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer
    • Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer
    • Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer
    • Endocrine Treatment and Targeted Therapy for HR-Positive, HER2-Negative Metastatic Breast Cancer
    • Chemo- and Targeted Therapy for Patients With HER2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative
  • ASCO Educational Book
    • What’s the Price? Toxicities of Targeted Therapies in Breast Cancer Care [2020]
  • Breast Cancer : Basic and Clinical Research
    • Endocrine Therapy Plus Anti-HER2 Therapy as Adjuvant Systemic Therapy for Luminal HER2-Positive Breast Cancer: An Analysis of the National Cancer Database [2020]
  • Breast Cancer : Targets and Therapy
    • Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis [2021]
  • Breast Cancer Research and Treatment
    • Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium [2020]
    • Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG) [2018]
    • Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG) [2018]
    • Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelines [2013]
  • Cancer Medicine
    • Physician experiences and preferences in the treatment of HR+/HER2- metastatic breast cancer in the United States: a physician survey [2015]
  • Cancers
    • Racial/Ethnic Differences and Trends in Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer [2022]
  • Chinese Clinical Oncology
    • Chemotherapy principles of managing stage IV breast cancer in the United States [2016]
  • Current Breast Cancer Reports
    • Lessons Learned: Management of Breast Cancer Patients throughout the COVID-19 Pandemic [2021]
  • Food and Drug Administration
    • FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor–Positive, HER2-Negative Metastatic Breast Cancer [2015]
  • JAMA Network Open
    • Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)–Positive Breast Cancer [2020]
  • JAMA Oncology
    • Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States [2017]
  • JCO Oncology Practice
    • Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach [2020]
  • Journal of Cancer
    • Current Approaches and Challenges in Monitoring Treatment Responses in Breast Cancer [2014]
  • Journal of Oncology Practice
    • Improved Breast Cancer Care Quality Metrics After Implementation of a Standardized Tumor Board Documentation Template [2015]
  • National Cancer Institute
    • Childhood Breast Cancer Treatment (PDQ®)
    • Breast Cancer Treatment (PDQ®)
  • National Comprehensive Cancer Network
    • NCCN Guidelines® Insights: Breast Cancer, Version 4.2021 [2021]
    • NCCN resource-stratified and harmonized guidelines: A paradigm for optimizing global cancer care [2020]
  • Society for Immunotherapy of Cancer
    • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer [2021]
  • Society for Integrative Oncology
    • Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment [2017]
• {Related topics}
  • Guidelines
    • Breast cancer treatment: vinca alkaloids
    • Breast cancer treatment: tyrosine kinase inhibitors
    • Breast cancer treatment: taxanes
    • Breast cancer treatment: surgery, radiotherapy
    • Breast cancer treatment: monoclonal antibodies
    • Breast cancer treatment: epothilones
    • Breast cancer treatment: bisphosphonates
    • Breast cancer treatment: aromatase inhibitors
    • Breast cancer treatment: antimetabolites
    • Breast cancer treatment: antiestrogens
    • Breast cancer treatment: anthracyclines
    • Breast cancer

Breast cancer treatment: anthracyclines

• China
  • Cancer Medicine
    • Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation-wide multicenter study [2021]
• Lebanon
  • BMC Cancer
    • Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients [2015]
• Netherlands
  • British Journal of Cancer
    • Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer [2018]
• Spain
  • Clinical and Translational Oncology
    • Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention [2017]
• United States
  • Journal of Clinical Oncology
    • Decline in the Use of Anthracyclines for Breast Cancer [2012]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: antiestrogens

• Australia, New Zealand
  • Royal Australian and New Zealand College of Obstetricians and Gynaecologists
    • Tamoxifen and the endometrium [2019]
• Europe
  • Breast
    • Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective [2017]
• International
  • Clinical Pharmacology & Therapeutics
    • Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy [2018]
• Republic of Korea
  • Frontiers in Oncology
    • Effect of Tamoxifen on the Risk of Osteoporosis and Osteoporotic Fracture in Younger Breast Cancer Survivors: A Nationwide Study [2020]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer [2018]
    • Fulvestrant for the treatment of locally advanced or metastatic breast cancer [2011]
• United States
  • American College of Medical Genetics and Genomics
    • Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy [2012]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: antimetabolites

• United Kingdom
  • National Institute for Health and Care Excellence
    • Gemcitabine for the treatment of metastatic breast cancer [2007]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: aromatase inhibitors

• Australia
  • Medical Services Advisory Committee
    • Bone mineral density analyses using Dual Energy X-Ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment [2015]
• Canada
  • Current Oncology
    • Endocrine therapy for postmenopausal women with hormone receptor–positive her2–negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement [2013]
• China
  • OncoTargets and therapy
    • Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective [2016]
• International
  • Journal of Bone Oncology
    • Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG [2017]
• Lithuania
  • Medicina
    • Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer: A consensus of Lithuanian medical oncologists, radiation oncologists, endocrinologists, and family medicine physicians [2014]
• United States
  • American College of Obstetricians and Gynecologists
    • Aromatase Inhibitors in Gynecologic Practice [2018]
  • Clinical Cardiology
    • Are Aromatase Inhibitors Associated with Higher Myocardial Infarction Risk in Breast Cancer Patients? A Medicare Population-Based Study [2018]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: bisphosphonates

• Australia
  • Cancer Australia
    • Recommendations for use of bisphosphonates in early breast cancer [2011]
    • Recommendations for use of bisphosphonates for advanced breast cancer [2011]
    • Bisphosphonates in early breast cancer: a systematic literature review [2011]
• Canada
  • Breast Cancer Research and Treatment
    • Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey [2021]
  • Journal of Bone Oncology
    • Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meeting [2015]
  • Ontario Health
    • Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer [2022]
• Canada, United States
  • American Society of Clinical Oncology
    • Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline [2017]
• Europe
  • Annals of Oncology
    • Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel [2016]
• International
  • Therapeutic Advances in Medical Oncology
    • The incidence and relative risk of adverse events in patients treated with bisphosphonate therapy for breast cancer: a systematic review and meta-analysis [2019]
• Singapore
  • Annals Academy of Medicine Singapore
    • Singapore Cancer Network (SCAN) Guidelines for Bisphosphonate Use in the Adjuvant Breast Cancer Setting [2015]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: epothilones

• Canada
  • BC Cancer Agency
    • Ixabepilone [2014]
• United States
  • Cancer Management and Research
    • Ixabepilone: a new treatment option for the management of taxane-resistant metastatic breast cancer [2009]
  • Drug Design, Development and Therapy
    • Management of advanced breast cancer with the epothilone B analog, ixabepilone [2009]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: monoclonal antibodies

• Australia
  • Medical Services Advisory Committee
    • Testing for HER2 positivity in patients diagnosed with breast cancer to determine eligibility for treatment with trastuzumab [2017]
• Austria
  • Oncologist
    • Influence of the American ODAC Statement on Austrian Bevacizumab Prescribing Practice for Metastatic Breast Cancer [2012]
• Colombia
  • Revista de Salud Pública
    • ErbB2+ metastatic breast cancer treatment after progression on trastuzumab: a cost-effectiveness analysis for a developing country [2014]
• Europe
  • ESMO Open
    • Flexible care in breast cancer [2021]
• Germany
  • BMC Cancer
    • Trastuzumab in advanced breast cancer - a decade of experience in Germany [2014]
  • Breast Care
    • Adopting Guidelines into Clinical Practice: Implementation of Trastuzumab in the Adjuvant Treatment of Breast Cancer in Lower Saxony, Germany, in 2007 [2011]
• India
  • JCO Global Oncology
    • Cost Effectiveness of Trastuzumab for Management of Breast Cancer in India [2020]
• International
  • Current Breast Cancer Reports
    • Incidence, Diagnosis, and Treatment of Cardiac Toxicity from Trastuzumab in Patients with Breast Cancer [2017]
• Iran
  • PharmacoEconomics
    • Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy [2018]
• Italy
  • Oncologist
    • Cardiovascular risk after adjuvant trastuzumab in early breast cancer: an Italian population-based cohort study [2020]
• Japan
  • Breast Cancer Research and Treatment
    • A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study [2019]
  • Molecular and Clinical Oncology
    • Pertuzumab for the treatment of patients with human epidermal growth factor receptor 2-positive breast cancer in Japan [2015]
• Netherlands
  • Breast Cancer Research and Treatment
    • Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry [2021]
  • Oncotarget
    • Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium [2017]
• New Zealand
  • PLoS Medicine
    • Adjuvant Trastuzumab in HER2-Positive Early Breast Cancer by Age and Hormone Receptor Status: A Cost-Utility Analysis [2016]
• Norway
  • Norwegian Institute of Public Health
    • Health Economic Analysis of Bevacizumab + Paclitaxel Versus Paclitaxel Alone as First-Line Treatment for Metastatic Breast Cancer [2009]
• Philippines
  • BMC Health Services Research
    • Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines [2019]
• Singapore
  • Annals Academy of Medicine Singapore
    • Singapore Cancer Network (SCAN) Guidelines for Adjuvant Trastuzumab Use in Early Stage HER2 Positive Breast Cancer [2015]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments [2023]
    • Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapies | Guidance | NICE [2021]
    • Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancer [2020]
    • Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer [2019]
    • Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer [2018]
    • Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxane [2017]
    • Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer [2016]
    • Early and metastatic HER2-positive breast cancer: subcutaneous trastuzumab [2013]
    • Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer [2012]
    • Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer [2011]
• United States
  • American Journal of Managed Care
    • Integrating Trastuzumab Biosimilars and HER2-Directed Therapies into HER2-Positive Breast Cancer Management [2020]
  • Journal of Clinical Oncology
    • Cardiac Surveillance Guidelines for Trastuzumab-Containing Therapy in Early-Stage Breast Cancer: Getting to the Heart of the Matter [2016]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: surgery, radiotherapy

• Africa
  • Journal of Global Oncology
    • Surgical Management of Breast Cancer in Africa: A Continent-Wide Review of Intervention Practices, Barriers to Care, and Adjuvant Therapy [2017]
• Australia
  • Australian Family Physician
    • Conservation surgery and radiation therapy in early breast cancer – An update [2017]
  • Better Safer Care
    • Double mastectomy for cancer in a single breast
  • Cancer Australia
    • Recommendations for use of hypofractionated radiotherapy for early (operable) breast cancer [2015]
    • Management of the axilla for early breast cancer: a systematic review [2011]
  • Medical Services Advisory Committee
    • Intraoperative Radiotherapy for Early Stage Breast Cancer [2017]
  • Radiotherapy and Oncology
    • Variation in the use of radiotherapy fractionation for breast cancer: Survival outcome and cost implications [2020]
• Austria, Germany, Switzerland
  • BMC Cancer
    • Are heart toxicities in breast cancer patients important for radiation oncologists? A practice pattern survey in German speaking countries [2017]
• Brazil
  • Revista da Associação Médica Brasileira
    • Recommendations for hypofractionated whole-breast irradiation [2018]
    • Treatment with intensity-modulated radiation therapy (IMRT) for breast cancer [2014]
• Canada
  • Breast Cancer Research and Treatment
    • COVID-19 vaccination and breast cancer surgery timing [2021]
  • Canadian Agency for Drugs and Technologies in Health
    • Intraoperative Mammography for Breast Cancer Surgery: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines [2019]
  • Canadian Family Physician
    • Breast reconstruction [2018]
  • Current Oncology
    • National Variations in the Work-Up, Investigation, and Surgical Management of Ductal Carcinoma In Situ of the Breast across Canadian Surgeons [2021]
    • Consensus statement on tumour bed localization for radiation after oncoplastic breast surgery [2020]
    • Locoregional therapy of locally advanced breast cancer: a clinical practice guideline [2015]
• China
  • Cancer Management and Research
    • Surgical Management Strategy for Breast Cancer Patients During the COVID-19 Outbreak [2020]
  • Chinese Medical Journal
    • Clinical practice guidelines for pre-operative evaluation of breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
    • Clinical practice guidelines for modified radical mastectomy of breast cancer: Chinese Society of Breast Surgery (CSBrs) practice guidelines 2021 [2021]
    • Clinical practice guidelines for endoscopic breast surgery in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
    • Clinical practice guideline for breast-conserving surgery in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
  • Journal of Cancer
    • Management of early-stage breast cancer patients during the coronavirus disease 2019 (COVID-19) pandemic: The experience in China from a surgical standpoint [2021]
  • Oncologist
    • Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals [2020]
• Denmark, Netherlands
  • Breast Cancer Research and Treatment
    • Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands [2020]
• Estonia
  • International Journal for Equity in Health
    • The impact of sociodemographic factors on the utilization of radiation therapy in breast cancer patients in Estonia: a register-based study [2021]
• Europe
  • Breast
    • A multidisciplinary view of mastectomy and breast reconstruction: Understanding the challenges [2021]
  • Clinical Oncology
    • Postmastectomy Radiation Therapy Planning After Immediate Implant-based Reconstruction Using the European Society for Radiotherapy and Oncology-Advisory Committee in Radiation Oncology Practice Consensus Guidelines for Target Volume Delineation [2021]
  • European Organisation for Research and Treatment of Cancer
    • Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal Radiotherapy (NORA) survey [2015]
  • European Society for Radiotherapy and Oncology
    • In regard to “The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria” [2021]
    • ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost – GEC-ESTRO Breast Cancer Working Group practical recommendations [2018]
  • European Society of Regional Anaesthesia and Pain Therapy
    • PROSPECT guideline for oncological breast surgery: a systematic review and procedure-specific postoperative pain management recommendations [2020]
  • Radiotherapy and Oncology
    • The changing landscape in radiotherapy for breast cancer: Lessons from long term follow-up in some European breast cancer trials [2016]
• France
  • Reports of Practical Oncology and Radiotherapy
    • Should the management of radiation therapy for breast cancer be standardized? Results of a survey on current French practices in breast radiotherapy [2021]
• Germany
  • Breast Care
    • Breast Cancer Surgery and Financial Reimbursement in Germany [2012]
  • Deutsche Gesellschaft für Radioonkologie
    • DEGRO practical guideline for partial-breast irradiation [2020]
    • DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences [2016]
    • DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases [2015]
    • DEGRO practical guidelines: radiotherapy of breast cancer I [2013]
  • Deutsches Ärzteblatt International
    • Case Numbers and Process Quality in Breast Surgery in Germany [2015]
  • Institute for Quality and Efficiency in Health Care
    • Relationship between volume of services and quality of treatment outcome in the surgical treatment of breast cancer - rapid report [2020]
• India
  • Indian Journal of Medical Research
    • Breast conservation surgery & oncoplasty in India – Current scenario [2021]
    • Adjuvant radiation therapy in breast cancer: Recent advances & Indian data [2021]
• International
  • BMJ Open
    • Evaluation of guidelines regarding surgical treatment of breast cancer using the AGREE Instrument: a systematic review [2017]
  • Breast
    • Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy [2022]
    • Should oncoplastic breast conserving surgery be used for the treatment of early stage breast cancer? Using the GRADE approach for development of clinical recommendations [2021]
  • Breast Cancer Research and Treatment
    • Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy [2018]
  • Cancer
    • Locoregional treatment of primary breast cancer. Consensus recommendations from an International Expert Panel [2010]
• Italy
  • Breast
    • Loco-regional adjuvant radiation therapy in breast cancer patients with positive axillary lymph-nodes at diagnosis (CN2) undergoing preoperative chemotherapy and with complete pathological lymph-nodes response. Development of GRADE (Grades of recommendation, assessment, Development and Evaluation) recommendation by the Italian Association of radiation therapy and Clinical Oncology (AIRO) [2021]
  • Journal of Breast Cancer
    • The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria [2021]
• Japan
  • Breast Cancer
    • The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition [2020]
    • The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition [2020]
• Netherlands
  • BJS
    • Nationwide population-based study of the impact of immediate breast reconstruction after mastectomy on the timing of adjuvant chemotherapy [2019]
  • Richtlijnendatabase
    • Breast reconstruction after mastectomy [2015]
• New Zealand
  • Ministry of Health New Zealand
    • Breast Reconstruction: National guidelines for best practice [2022]
    • Intraoperative radiotherapy for patients with early-stage breast cancer in New Zealand: An economic assessment [2017]
• Republic of Korea
  • Journal of Breast Cancer
    • Patterns of Practice in Radiotherapy for Breast Cancer in Korea [2018]
    • The Practice Patterns and Perceptions of Korean Surgeons Regarding Margin Status after Breast-Conserving Surgery [2017]
  • Journal of Korean Medical Science
    • Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea [2021]
  • Medicine
    • Trends in the Application of Postmastectomy Radiotherapy for Breast Cancer With 1 to 3 Positive Axillary Nodes and Tumors <=5cm in the Modern Treatment Era [2016]
• Turkey
  • JCO Global Oncology
    • Surgical Trends in Breast Cancer in Turkey: An Increase in Breast-Conserving Surgery [2020]
• Uganda
  • PLoS ONE
    • Breast cancer care in Uganda: A multicenter study on the frequency of breast cancer surgery in relation to the incidence of breast cancer [2019]
• United Kingdom
  • Annals of The Royal College of Surgeons of England
    • Guidelines for oncoplastic breast reconstruction [2013]
  • Association of Breast Surgery
    • Oncoplastic breast surgery: A guide to good practice [2021]
    • Biological and synthetic mesh assisted breast reconstruction procedures: Joint guidelines from the Association of Breast Surgery and the British Association of Plastic, Reconstructive and Aesthetic Surgeons [2021]
    • Guidance for the Commissioning of Oncoplastic Breast Surgery [2018]
    • Contralateral Mastectomy for Unilateral Breast Cancer [2017]
    • Margin Width in Breast Conservation Surgery [2015]
    • National Mastectomy and Breast Reconstruction Audit [2011]
  • British Journal of Surgery
    • Ethnicity and the surgical management of early invasive breast cancer in over 164 000 women [2021]
  • European Journal of Surgical Oncology
    • A scoring system for 3D surface images of breast reconstruction developed using the Delphi consensus process [2020]
    • Adherence to best practice consensus guidelines for implant-based breast reconstruction: Results from the iBRA national practice questionnaire survey [2018]
  • National Institute for Health and Care Excellence
    • Intrabeam radiotherapy system for adjuvant treatment of early breast cancer [2018]
    • AlignRT in breast cancer radiotherapy [2018]
    • L-Dex U400 for lymphoedema after breast cancer treatment [2017]
    • Axxent electronic brachytherapy system for early stage breast cancer [2016]
    • Breast reconstruction using lipomodelling after breast cancer treatment [2012]
    • Endoscopic mastectomy and endoscopic wide local excision for breast cancer [2009]
  • NHS England
    • Radiotherapy after primary surgery for breast cancer [2016]
  • Royal College of Pathologists
    • Postoperative radiotherapy for breast cancer: UK consensus statements [2016]
  • World Journal of Surgical Oncology
    • The Manchester guidelines for contralateral risk-reducing mastectomy [2015]
• United States
  • Advances in Radiation Oncology
    • The Association Between Cardiac Mortality and Adjuvant Radiation Therapy Among Older Patients With Stage I Estrogen Positive Breast Cancer: A Surveillance, Epidemiology, and End Results (SEER)–Based Study on Cardiac Mortality and Radiation Therapy [2020]
  • Agency for Healthcare Research and Quality
    • Partial Breast Irradiation for Breast Cancer [2023]
    • Breast Reconstruction After Mastectomy [2021]
  • American College of Radiology
    • ACR Appropriateness Criteria® Ductal Carcinoma in Situ [2015]
    • Imaging of Deep Inferior Epigastric Arteries for Surgical Planning (Breast Reconstruction Surgery)
    • Conservative surgery and radiation - stage I and II breast cancer
  • American College of Surgeons
    • COVID-19 Pandemic Breast Cancer Consortium’s Considerations for Re-entry [2020]
    • COVID-19 Guidelines for Triage of Breast Cancer Patients [2020]
  • American Physical Therapy Association
    • Interventions for Breast Cancer–Related Lymphedema: Clinical Practice Guideline From the Academy of Oncologic Physical Therapy of APTA [2020]
  • American Society for Radiation Oncology
    • Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement [2017]
    • Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer [2014]
    • Fractionation for Whole Breast Irradiation: An American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline [2011]
  • American Society of Breast Surgeons
    • Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks [2016]
    • Contralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making [2016]
    • Toolbox to Reduce Lumpectomy Reoperations and Improve Cosmetic Outcome in Breast Cancer Patients: The American Society of Breast Surgeons Consensus Conference [2015]
    • Official Statements
  • American Society of Clinical Oncology
    • Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ [2016]
    • Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update [2016]
  • Annals of Surgical Oncology
    • Assessment of Practice Patterns Following Publication of the SSO–ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer [2015]
  • Breast
    • Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability [2021]
  • International Journal of Surgery
    • Are the American Society for Radiation Oncology Guidelines Accurate Predictors of Recurrence in Early Stage Breast Cancer Patients Treated with Balloon-Based Brachytherapy? [2013]
  • JAMA
    • Uptake and Costs of Hypofractionated vs Conventional Whole Breast Irradiation After Breast Conserving Surgery in the United States, 2008–2013 [2014]
  • JAMA Oncology
    • Temporal Trends in Post-Mastectomy Radiation Therapy and Breast Reconstruction [2016]
  • M.D. Anderson Cancer Center
    • Evolution in Surgical Management of Breast Cancer-related Lymphedema: The MD Anderson Cancer Center Experience [2020]
    • DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes [2017]
    • Breast reconstruction at the MD Anderson Cancer Center [2016]
  • Medicine
    • Impact of lack of surgery on outcomes in elderly women with nonmetastatic breast cancer-A surveillance, epidemiology, and end results 18 population based study [2020]
  • National Comprehensive Cancer Network
    • Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology [2016]
  • NPJ Breast Cancer
    • Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint [2018]
  • Plastic and Reconstructive Surgery Global Open
    • Breast Reconstruction in Inflammatory Breast Cancer: An Analysis of Predictors, Trends, and Survival from the National Cancer Database [2021]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: taxanes

• Australia
  • Cancer Australia
    • Recommendations for use of taxane-containing chemotherapy regimens for the treatment of early (operable) breast cancer [2008]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Use of Taxanes in Metastatic HER2-negative Breast Cancer – a Status Report [2020]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: tyrosine kinase inhibitors

• Brazil
  • Breast Cancer : Targets and Therapy
    • Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective [2012]
• China
  • Experimental and Therapeutic Medicine
    • Tyrosine kinase inhibitors in breast cancer (Review) [2022]
  • OncoTargets and therapy
    • Lapatinib for the treatment of breast cancer in the People’s Republic of China [2014]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumab [2019]
• United States
  • Future Medicine
    • Neratinib: the emergence of a new player in the management of HER2+ breast cancer brain metastasis [2020]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast cancer treatment: vinca alkaloids

• China
  • Cancer Chemotherapy and Pharmacology
    • Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer [2020]
• Poland
  • Contemporary Oncology
    • Evaluation of vinorelbine-based chemotherapy as the second or further-line treatment in patients with metastatic breast cancer [2013]
• Taiwan
  • Journal of Cancer
    • Metronomic vinorelbine is an excellent and safe treatment for advanced breast cancer: a retrospective, observational study [2021]
• {Related topics}
  • Guidelines
    • Breast cancer treatment

Breast imaging

• Asia
  • Diagnostics
    • Is Ultrasound an Accurate Alternative for Mammography in Breast Cancer Screening in an Asian Population? A Meta-Analysis [2020]
• Australia
  • Journal of Medical Radiation Sciences
    • MRI screening for breast cancer in women at high risk; is the Australian breast MRI screening access program addressing the needs of women at high risk of breast cancer? [2015]
  • Medical Services Advisory Committee
    • Breast Magnetic Resonance Imaging for improved definition of the breast cancer primary [2018]
    • Breast Magnetic Resonance Imaging (MRI) [2015]
    • Review of Interim Funded Service: Breast MRI [2014]
• Australia, New Zealand
  • Australasian Society for Ultrasound in Medicine
    • Guidelines on Breast Ultrasound Examination and Reporting [2018]
• Canada
  • Canadian Association of Radiologists
    • COVID-19: Safe Guidelines for Breast Imaging During the Pandemic [2020]
    • Breast Imaging and Intervention [2016]
  • Ontario Health
    • Preoperative Breast Magnetic Resonance Imaging [2021]
    • Baseline Staging Imaging for Distant Metastasis in Women with Stage I, II, and III Breast Cancer [2019]
    • The Utility of PET/CT in Breast Cancer (Stages II-IV): An Evidence Summary [2014]
    • Effectiveness of Screening With Annual Magnetic Resonance Imaging and Mammography: Results of the Initial Screen From the Ontario High Risk Breast Screening Program [2014]
• China
  • Journal of Cancer Research and Therapeutics
    • Chinese association of ultrasound in medicine and engineering, superficial organs and peripheral vessels committee expert consensus on clinical frequently asked questions in breast ultrasonography, June 2018 [2018]
• Europe
  • European Commission
    • Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC) [2021]
  • European Society of Breast Imaging
    • Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI) [2021]
    • Diffusion-weighted imaging of the breast—a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group [2019]
    • Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging [2018]
    • A survey by the European Society of Breast Imaging on the utilisation of breast MRI in clinical practice [2017]
    • Breast MRI: EUSOBI recommendations for women’s information [2015]
    • Breast MRI: guidelines from the European Society of Breast Imaging [2008]
• Germany
  • Breast Care
    • Consensus Meeting of Breast Imaging: BI-RADS® and Beyond [2019]
  • RöFo
    • Updated Recommendations for MRI of the Breast [2014]
  • Ultraschall in der Medizin
    • Best Practice Guideline – DEGUM Recommendations on Breast Ultrasound – Part I – Examination technique, DEGUM ultrasound criteria, and documentation [2021]
• International
  • World Federation for Ultrasound in Medicine and Biology
    • WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 2: Breast [2015]
• Italy
  • La radiologia medica
    • Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM [2020]
• Japan
  • Annals of Nuclear Medicine
    • Clinical practice guidelines for high-resolution breast PET, 2019 edition [2021]
    • Clinical practice guideline for dedicated breast PET [2014]
• Netherlands
  • JAMA Oncology
    • Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk [2020]
• Republic of Korea
  • Ultrasonography
    • Practice guideline for the performance of breast ultrasound elastography [2014]
• South Africa
  • SA Journal of Radiology
    • Understanding indications and defining guidelines for breast magnetic resonance imaging [2018]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Aixplorer ShearWave Elastography for ultrasound imaging and assessing suspicious breast lesions [2014]
  • Public Health England
    • Breast screening: reporting breast images from home
    • Breast screening: quality assurance for medical physics services
    • Breast screening: imaging equipment evaluation and protocol
  • Royal College of Radiologists
    • Guidance on screening and symptomatic breast imaging, Fourth edition [2019]
    • The breast imaging and diagnostic workforce in the United Kingdom [2016]
• United States
  • American College of Radiology
    • ACR Appropriateness Criteria® Imaging After Mastectomy and Breast Reconstruction [2020]
    • Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer [2010]
    • Palpable Breast Masses
    • Evaluation of Nipple Discharge
    • Breast Pain
    • Breast Imaging of Pregnant and Lactating Women
    • ACR Practice Parameter for the Performance of a Breast Ultrasound Examination
    • ACR Practice Parameter for the Performance of Molecular Breast Imaging (MBI) Using a Dedicated Gamma Camera
  • Breast Cancer Surveillance Consortium
    • Prioritizing breast imaging services during the COVID pandemic: A survey of breast imaging facilities within the Breast Cancer Surveillance Consortium [2021]
    • Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk [2019]
    • Is Breast MRI Better at Finding Second Breast Cancers than Mammograms Alone for Breast Cancer Survivors? [2019]
  • Breast Journal
    • Screening Magnetic Resonance Imaging Recommendations and Outcomes in Patients at High Risk for Breast Cancer [2015]
  • Cancer
    • Disparities in the Use of Screening Breast MRI in Community Practice by Race, Ethnicity and Socioeconomic Status [2015]
• {Related topics}
  • Guidelines
    • Mammography
    • Breast cancer screening
    • Breast cancer diagnosis
    • Breast cancer
    • Benign breast diseases

Breast plastic surgery

• Australia
  • Australian Institute of Health and Welfare
    • Breast implants: A guide for general practice [2021]
  • Medical Services Advisory Committee
    • Autologous fat grafting (AFG) by injection, for defects arising from breast surgery, cancer treatment/prevention or congenital deformity [2020]
    • Breast Magnetic Resonance Imaging for Breast Implant Associated Anaplastic Large Cell Lymphoma [2017]
  • Royal Australian College of General Practitioners
    • Recommended management of a patient with a breast implant [2020]
• Australia, New Zealand
  • Plastic and Reconstructive Surgery Global Open
    • Breast Implant Selection: Consensus Recommendations Using a Modified Delphi Method [2019]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Povidone-Iodine for Breast Implant Surgery: A Review of Clinical Effectiveness and Guidelines [2019]
• Denmark
  • Danish Medical Journal
    • Poor adherence to clinical guidelines for women undergoing breast reduction [2016]
• Europe, United States
  • Plastic and Reconstructive Surgery Global Open
    • Breast Implant Utilization Trends in USA versus Europe and the Impact of BIA-ALCL Publications [2021]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • Biological Matrices and Synthetic Meshes Used in Implant-based Breast Reconstruction – a Review of Products Available in Germany [2013]
• International
  • Aesthetic Surgery Journal
    • Expert Consensus on the Use of a New Bioengineered, Cell-Friendly, Smooth Surface Breast Implant [2019]
  • BMC Surgery
    • A systematic review and meta-analysis of risks and benefits with breast reduction in the public healthcare system: priorities for further research [2021]
  • European Journal of Breast Health
    • New Data on the Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma [2021]
• Ireland
  • Ireland's Health Services
    • Breast Implant Associated Anaplastic Large Cell Lymphoma - BIA-ALCL Report [2021]
• Israel
  • Israel Medical Association Journal
    • Breast Implantation Rates in Israel: Is There a Change in Trend? [2021]
• Netherlands
  • Aesthetic Surgery Journal
    • Breast Implant Prevalence in the Dutch Female Population Assessed by Chest Radiographs [2020]
• United Kingdom
  • Association of Breast Surgery
    • UK Guidelines for Lipomodelling of the Breast on behalf of Plastic, Reconstructive and Aesthetic Surgery and Association of Breast Surgery Expert Advisory Group [2021]
    • Breast Implant Associated-Anaplastic Large Cell Lymphoma [2017]
  • Medicines and Healthcare products Regulatory Agency
    • UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG) [2021]
  • NHS Digital
    • Breast and Cosmetic Implant Registry
  • Public Health England
    • Breast screening: imaging women with breast implants
  • Royal College of Surgeons
    • Breast Reduction Surgery - Commissioning Guide [2014]
• United States
  • American College of Radiology
    • Breast Implant Evaluation
  • Food and Drug Administration
    • Breast Implants
  • Journal of Clinical Oncology
    • Best Practices Guideline for the Pathologic Diagnosis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma [2020]
  • National Comprehensive Cancer Network
    • 2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) [2019]
    • NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma [2017]
  • Plastic and Reconstructive Surgery
    • Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Initial Report of Findings 2012 – 2018 [2019]
  • Plastic Surgery
    • Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Current Understanding and Recommendations for Management [2020]
  • Seminars in Plastic Surgery
    • Finding Consensus After Two Decades of Breast Implant-Associated Anaplastic Large Cell Lymphoma [2019]
• {Related topics}
  • Guidelines
    • Breast cancer treatment
    • Breast cancer
    • Benign breast diseases

Familial breast cancer

• Africa
  • International Journal of Breast Cancer
    • Breast Cancer in Africa: Limitations and Opportunities for Application of Genomic Medicine [2016]
  • SpringerPlus
    • Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? – a systematic review [2012]
• Asia
  • Journal of Medical Genetics
    • Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries [2015]
• Australia
  • Cancer Australia
    • Recommendations for the management of early breast cancer in women with an identified BRCA1 or BRCA2 gene mutation or at high risk of a gene mutation [2014]
• Canada
  • Canadian Family Physician
    • Identification and management of women with a family history of breast cancer: Practical guide for clinicians [2016]
• China
  • Chinese Medical Journal
    • Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021 [2021]
  • Journal of Epidemiology
    • Hereditary Breast Cancer in the Han Chinese Population [2013]
  • PLoS ONE
    • Identification of a Comprehensive Spectrum of Genetic Factors for Hereditary Breast Cancer in a Chinese Population by Next-Generation Sequencing [2015]
• Europe
  • European Journal of Cancer
    • Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations [2019]
  • European Society for Medical Oncology
    • BRCA in breast cancer: ESMO Clinical Practice Guidelines [2011]
  • Journal of Community Genetics
    • Genetic testing for familial/hereditary breast cancer—comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany [2011]
• Germany
  • Cancer Medicine
    • Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer [2018]
• International
  • Breast
    • Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis [2021]
  • Breast Cancer Research
    • Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers [2020]
  • Cancer Management and Research
    • A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer [2019]
  • Cancer Medicine
    • A systematic review of recommendations on screening strategies for breast cancer due to hereditary predisposition: Who, When, and How? [2021]
  • Clinical Epidemiology
    • A systematic review of the international prevalence of BRCA mutation in breast cancer [2019]
  • New England Journal of Medicine
    • Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk [2015]
• Iran
  • Journal of Research in Medical Sciences
    • BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review [2015]
• Ireland
  • Health Information and Quality Authority
    • HTA of High Risk Breast Cancer Surveillance [2013]
• Japan
  • Journal of Human Genetics
    • The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database [2021]
• Latin America
  • Revista de Investigación Clínica
    • Genetic Cancer Risk Assessment for Breast Cancer in Latin America [2017]
• Mexico
  • Salud Pública de México
    • Genetics of breast cancer: Applications to the Mexican population [2011]
• Netherlands
  • European Journal of Human Genetics
    • Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population [2014]
• Norway
  • BMC Cancer
    • Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers [2017]
  • Norwegian Institute of Public Health
    • Diagnostic accuracy, clinical effectiveness and budget impact of screening BRCA1/2 mutation carriers by MRI. A health technology assessment [2018]
• Republic of Korea
  • Archives of Plastic Surgery
    • Perceptions of Prophylactic Mastectomy in Korea [2016]
  • International Journal of Environmental Research and Public Health
    • Association of Family History with the Development of Breast Cancer: A Cohort Study of 129,374 Women in KoGES Data [2021]
  • Journal of Breast Cancer
    • The Korean Hereditary Breast Cancer Study: Review and Future Perspectives [2013]
• Singapore
  • Chinese Clinical Oncology
    • The management of BRCA1 and BRCA2 carriers in Singapore [2020]
• Slovenia
  • European Journal of Surgical Oncology
    • Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia [2021]
• Spain
  • PLoS ONE
    • Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM “El Álamo III” retrospective study [2017]
• United Arab Emirates
  • Breast
    • Clinicopathological characteristics of gene-positive breast cancer in the United Arab Emirates [2020]
• United Kingdom
  • Association of Breast Surgery
    • Overview of the Implications and Implementation of NICE Guidelines on Familial Breast Cancer [2015]
  • Breast Cancer Research and Treatment
    • Family history and risk of breast cancer: an analysis accounting for family structure [2017]
  • British Journal of General Practice
    • Dealing with family history of breast cancer: something new, something old [2014]
  • Healthcare Improvement Scotland
    • Familial breast cancer report [2014]
  • Journal of Community Genetics
    • Specialist recommendation for chemoprevention medications in patients at familial risk of breast cancer: a cross-sectional survey in England [2021]
  • Journal of Medical Genetics
    • Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services [2021]
  • National Institute for Health and Care Excellence
    • Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer [2019]
• United States
  • Agency for Healthcare Research and Quality
    • Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer [2013]
  • American Journal of Human Genetics
    • Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer [2016]
  • American Society of Breast Surgeons
    • Consensus Guidelines on Genetic Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons [2019]
  • American Society of Clinical Oncology
    • Adjuvant PARP Inhibitors in Patients With High-Risk Early-Stage HER2-Negative Breast Cancer and Germline BRCA Mutations: ASCO Hereditary Breast Cancer Guideline Rapid Recommendation Update [2021]
    • Management of Hereditary Breast Cancer
  • Breast Cancer
    • Do current family history-based genetic testing guidelines contribute to breast cancer health inequities? [2022]
  • Breast Cancer Surveillance Consortium
    • Family history of breast cancer, breast density, and breast cancer risk in a U.S. breast cancer screening population [2017]
    • Emerging Trends in Family History of Breast Cancer and Associated Risk [2017]
  • Journal of Community Genetics
    • Psychosocial approaches to participation in BRCA1/2 genetic risk assessment among African American women: a systematic review [2014]
• {Related topics}
  • Guidelines
    • Hereditary gynecologic cancer, genetic predisposition
    • Gynecologic oncology
    • Breast cancer risk
    • Breast cancer

Gynecomastia

• Canada
  • Plastic Surgery
    • Is routine pathological evaluation of tissue from gynecomastia necessary? A 15-year retrospective pathological and literature review [2014]
• Europe
  • European Academy of Andrology
    • EAA clinical practice guidelines—gynecomastia evaluation and management [2019]
• Germany
  • Strahlentherapie und Onkologie
    • Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer : Statement from the DEGRO working group prostate cancer [2020]
• United Kingdom
  • Association of Breast Surgery
    • Investigation and management of gynaecomastia in primary & secondary care [2021]
• United States
  • American College of Radiology
    • Evaluation of the Symptomatic Male Breast
• {Related topics}
  • Guidelines
    • Male hypogonadism, andropause
    • Benign breast diseases

Mammography

• Asia
  • Cancer Medicine
    • At what age should screening mammography be recommended for Asian women? [2015]
• Australia
  • Cancer Australia
    • Overdiagnosis from mammographic screening [2014]
  • Clinical Oncology Society of Australia
    • Mammographic / Breast Density - Facts and Issues paper [2021]
  • Journal of Clinical Medicine
    • Breast Density Notification: An Australian Perspective [2020]
• Brazil
  • Radiologia Brasileira
    • Contribution of the Unified Health Care System to mammography screening in Brazil, 2013 [2016]
  • Revista da Associação Médica Brasileira
    • Breast cancer screening in Brazil. Barriers related to the health system [2017]
• Canada
  • BMJ
    • Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial [2014]
  • Canadian Agency for Drugs and Technologies in Health
    • Digital Breast Tomosynthesis for the Screening and Diagnosis of Breast Cancer: A Review of the Diagnostic Accuracy, Cost-Effectiveness and Guidelines [2019]
  • Canadian Family Physician
    • Examining screening mammography participation among women aged 40 to 74 [2017]
  • Canadian Journal of Surgery
    • CJS debate: Is mammography useful in average-risk screening for breast cancer? [2016]
  • CMAJ Open
    • The cost-effectiveness of adding tomosynthesis to mammography-based breast cancer screening: an economic analysis [2021]
  • PLOS Computational Biology
    • Is mammography screening beneficial: An individual-based stochastic model for breast cancer incidence and mortality [2020]
• Chile
  • Breast
    • Mammogram screening in Chile: Using mixed methods to implement health policy planning at the primary care level [2011]
  • Revista de Saúde Pública
    • Effectiveness of breast cancer screening policies in countries with medium-low incidence rates [2018]
• Denmark
  • Clinical Epidemiology
    • Morbidity as a Predictor for Participation in the Danish National Mammography Screening Program: A Cross-Sectional Study [2020]
    • Danish Quality Database for Mammography Screening [2016]
• Developing countries
  • SpringerPlus
    • Mammography screening in less developed countries [2015]
• Europe
  • BMC Cancer
    • The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review [2018]
  • BMC Public Health
    • Development of breast cancer mortality considering the implementation of mammography screening programs – a comparison of western European countries [2019]
  • Cancer Epidemiology Biomarkers & Prevention
    • European Breast Cancer Service Screening Outcomes: A First Balance Sheet of the Benefits and Harms [2014]
  • European Commission
    • Digital breast tomosynthesis compared to diagnostic mammographic projections (including magnification) among women recalled at screening mammography: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC) [2021]
  • European Society of Breast Imaging
    • Mammography: an update of the EUSOBI recommendations on information for women [2017]
• Finland
  • International Journal of Cancer
    • Cancer incidence and mortality patterns in women with breast symptoms in the mammography screening programme: A matched cohort analysis [2019]
• Germany
  • Breast Care
    • Relevance of Health Economics in the Early Detection of Breast Cancer in Germany – the View of the Professional Association of Practicing Gynecologic Oncologists e.V. (BNGO) [2013]
  • Frontiers in Oncology
    • Assessing and Explaining Geographic Variations in Mammography Screening Participation and Breast Cancer Incidence [2019]
  • Institute for Quality and Efficiency in Health Care
    • Review of age limits in the mammography screening programme [2022]
  • International Journal of Cancer
    • Breast cancer incidence and mortality before and after implementation of the German mammography screening program [2020]
  • RöFo
    • Guideline for determining the mean glandular dose according to DIN 6868-162 and threshold contrast visibility according to the quality assurance guideline for digital mammography systems [2014]
• Iceland
  • Breast Cancer : Targets and Therapy
    • Population-based service mammography screening: the Icelandic experience [2013]
• International
  • Cancers
    • Worldwide Review and Meta-Analysis of Cohort Studies Measuring the Effect of Mammography Screening Programmes on Incidence-Based Breast Cancer Mortality [2020]
• Iran
  • Iranian Journal of Cancer Prevention
    • Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women [2016]
• Italy
  • Epidemiologia e Prevenzione
    • Problems, solutions, and perspectives in the evaluation of interval cancers in Italian mammography screening programmes: a position paper from the Italian group for mammography screening (GISMa) [2015]
  • La radiologia medica
    • Digital breast tomosynthesis (DBT): recommendations from the Italian College of Breast Radiologists (ICBR) by the Italian Society of Medical Radiology (SIRM) and the Italian Group for Mammography Screening (GISMa) [2017]
• Kuwait
  • Annals of Saudi Medicine
    • Kuwait National Mammography Screening Program: outcomes of 5 years of screening in Kuwaiti women [2021]
• Latin America and the Caribbean
  • Pan American Health Organization
    • Mammography Services Quality Assurance: Baseline Standards for Latin America and the Caribbean [2016]
• Lithuania
  • Acta Medica Lituanica
    • Breast Cancer Screening Program in Lithuania: Trends in Breast Cancer Mortality Before and During the Introduction of the Mammography Screening Program [2020]
  • Cancer Control
    • Trends in Breast Cancer Incidence and Stage Distribution Before and During the Introduction of the Mammography Screening Program in Lithuania [2019]
  • International Journal of Environmental Research and Public Health
    • Predictors and Trend in Attendance for Breast Cancer Screening in Lithuania, 2006–2014 [2019]
• Mexico
  • Revista de Investigación Clínica
    • Estimation of the Cost-Effectiveness of Breast Cancer Screening Using Mammography in Mexico Through a Simulation [2016]
• Netherlands
  • BMJ
    • Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study [2017]
• Portugal
  • European Journal of Public Health
    • Mammography use for breast cancer screening in Portugal: results from the 2005/2006 National Health Survey [2013]
  • Preventing Chronic Disease: Public Health Research, Practice and Policy
    • Mammography Use in Portugal: National Health Survey 2014 [2017]
• Republic of Korea
  • BMC Women's Health
    • Retrospective observation on contribution and limitations of screening for breast cancer with mammography in Korea: detection rate of breast cancer and incidence rate of interval cancer of the breast [2016]
  • Korean Journal of Radiology
    • Performance of Screening Mammography: A Report of the Alliance for Breast Cancer Screening in Korea [2016]
    • Clinical Image Evaluation of Film Mammograms in Korea: Comparison with the ACR Standard [2013]
• Singapore
  • PLoS ONE
    • Factors associated with false-positive mammography at first screen in an Asian population [2019]
• South Africa
  • SA Journal of Radiology
    • Screening mammography with special reference to guidelines in South Africa [2018]
• Spain
  • PLoS ONE
    • Cost-Effectiveness of Double Reading versus Single Reading of Mammograms in a Breast Cancer Screening Programme [2016]
    • Association between the Adherence to the International Guidelines for Cancer Prevention and Mammographic Density [2015]
• Sweden
  • Journal of the Royal Society of Medicine
    • Statistical analyses in Swedish randomised trials on mammography screening and in other randomised trials on cancer screening: a systematic review [2015]
• Switzerland
  • New England Journal of Medicine
    • Abolishing Mammography Screening Programs? A View from the Swiss Medical Board [2014]
  • Swiss Medical Weekly
    • Controversies in the mammography screening programme in Switzerland [2014]
• United Kingdom
  • Association of Breast Surgery
    • Duration and frequency of surveillance mammography after primary breast cancer treatment [2015]
  • BMJ Open
    • Improving screening recall services for women with false-positive mammograms: a comparison of qualitative evidence with UK guidelines [2015]
  • British Journal of Cancer
    • Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom [2014]
  • Healthcare Improvement Scotland
    • Digital breast tomosynthesis (DBT) - breast screening recall: Advice Statement [2018]
    • Digital breast tomosynthesis (DBT) - asymptomatic women attending breast screening: Advice Statement [2018]
  • National Institute for Health and Care Excellence
    • Contrast-enhanced spectral mammography for breast cancer [2022]
    • Artificial intelligence in mammography [2021]
  • Public Health England
    • Breast screening: routine quality control tests for breast tomosynthesis
    • Breast screening: repeat mammograms
    • Breast screening: remote radiographic supervision
    • Breast screening: manage mammograms and records
    • Breast screening: mammography equipment technical and practical evaluation reports
    • Breast screening: implementing remote image reading
    • Breast screening: guidance on partial or incomplete screening mammography
    • Breast screening: guidance for breast screening mammographers
    • Breast screening: ergonomics in screening mammography
    • Breast screening: digital breast tomosynthesis
• United States
  • Agency for Healthcare Research and Quality
    • Screening for Breast Cancer With Digital Breast Tomosynthesis [2016]
  • American College of Obstetricians and Gynecologists
    • The U.S. Food and Drug Administration Requires Notification of Breast Density in Mammography Reports [2023]
    • Management of Women With Dense Breasts Diagnosed by Mammography [2015]
  • American College of Radiology
    • Breast Cancer Screening Recommendations Inclusive of All Women at Average Risk: Update from the ACR and Society of Breast Imaging [2021]
    • ACR Statement on Reporting Breast Density in Mammography Reports and Patient Summaries [2017]
    • ACR Position Statement on Screening Mammography and Health Care Coverage [2016]
    • ACR–AAPM–SIIM Practice Parameter for Determinants of Image Quality In Digital Mammography
    • ACR Practice Parameter for the Performance of Screening and Diagnostic Mammography
    • ACR Practice Parameter for the Performance of Digital Breast Tomosynthesis (DBT)
  • American Journal of Roentgenology
    • Beyond the Mammography Quality Standards Act: Measuring the Quality of Breast Cancer Screening Programs [2014]
  • Annals of Internal Medicine
    • Aggregate Cost of Mammography Screening in the United States: Comparison of Current Practice and Advocated Guidelines [2014]
  • Breast Cancer Surveillance Consortium
    • Trends in Clinical Breast Density Assessment From the Breast Cancer Surveillance Consortium [2019]
    • Quantifying performance thresholds for recommending screening mammography: a revealed preference analysis of USPSTF guidelines [2018]
    • National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium [2017]
    • Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline [2017]
  • Cancer
    • Performance of digital screening mammography among older women in the U.S [2014]
    • Mammographic Screening Interval in Relation to Tumor Characteristics and False-positive Risk by Race/Ethnicity and Age [2013]
  • Cancer Epidemiology Biomarkers & Prevention
    • Do Community Health Worker Interventions Improve Rates of Screening Mammography in the United States? A Systematic Review [2011]
  • Cancer Medicine
    • Factors associated with mammography use: A side-by-side comparison of results from two national surveys [2020]
  • Centers for Disease Control and Prevention
    • Mammography
  • Food and Drug Administration
    • Mammography Quality Standards Act and Program
  • JAMA Internal Medicine
    • The Divide Between Breast Density Notification Laws and Evidence-Based Guidelines for Breast Cancer Screening [2015]
  • Journal of Women's Health
    • Screening Mammography Among Older Women: A Review of United States Guidelines and Potential Harms [2019]
    • Prevalence of Out-Of-Pocket Payments for Mammography Screening Among Recently Screened Women [2019]
  • National Academies Press
    • Assessing and Improving the Interpretation of Breast Images [2015]
  • PLoS ONE
    • Impact of the 2009 US Preventive Services Task Force Guidelines on Screening Mammography Rates on Women in Their 40s [2014]
  • Radiology
    • Registry-based Study of Trends in Breast Cancer Screening Mammography before and after the 2009 U.S. Preventive Services Task Force Recommendations [2014]
• WHO
  • World Health Organization
    • WHO position paper on mammography screening [2014]
• {Related topics}
  • Guidelines
    • Breast imaging
    • Breast cancer screening
    • Breast cancer diagnosis
    • Breast cancer
    • Benign breast diseases

Mastitis

• Australia
  • Australian Family Physician
    • Lactational mastitis and breast abscess - Diagnosis and management in general practice [2011]
• Eastern and Southern Africa
  • International Breastfeeding Journal
    • Prevalence of and factors associated with lactational mastitis in eastern and southern Africa: an exploratory analysis of community-based household surveys [2022]
• Europe
  • Nutrients
    • Subclinical Mastitis in a European Multicenter Cohort: Prevalence, Impact on Human Milk (HM) Composition, and Association with Infant HM Intake and Growth [2019]
• Germany
  • Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften
    • S3-Guidelines for the Treatment of Inflammatory Breast Disease during the Lactation Period [2013]
• International
  • Journal of Human Lactation
    • Incidence of and Risk Factors for Lactational Mastitis: A Systematic Review [2020]
• United Kingdom
  • BJS
    • Best-practice care pathway for improving management of mastitis and breast abscess [2018]
• United States
  • Academy of Breastfeeding Medicine
    • ABM Clinical Protocol #4: Mastitis, Revised March 2014 [2014]
• WHO
  • World Health Organization
    • Mastitis: causes and management [2000]
• {Related topics}
  • Guidelines
    • Breastfeeding complications
    • Benign breast diseases

Sentinel lymph node biopsy

• Australia
  • Cancer Australia
    • Recommendations for staging and managing the axilla in early (operable) breast cancer [2011]
• Canada
  • Canadian Agency for Drugs and Technologies in Health
    • Magnetic Localization System for Sentinel Lymph Node Biopsy: A Review of the Diagnostic Accuracy, Cost-Effectiveness, and Guidelines [2020]
    • Sentinel Lymph Node Biopsy for the Management of Breast Cancer: A Review of Guidelines [2019]
• Canada, United States
  • American Society of Clinical Oncology
    • Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline [2021]
• China
  • Chinese Medical Journal
    • Clinical practice guidelines for sentinel lymph node biopsy in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021 [2021]
  • Scientific Reports
    • The feasibility of the ACOSOG Z0011 Criteria to Chinese Breast Cancer Patients: A Multicenter Study [2015]
• Germany
  • Geburtshilfe und Frauenheilkunde
    • AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update [2021]
• International
  • International Collaboration on Cancer Reporting
    • Surgically Removed Lymph Nodes for Breast Tumours [2021]
• Netherlands
  • Annals of Surgical Oncology
    • What to Do with Non-visualized Sentinel Nodes? A Dutch Nationwide Survey Study [2017]
  • Breast Cancer Research and Treatment
    • Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy [2016]
• Sweden
  • Breast Cancer Research and Treatment
    • Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer [2017]
• United Kingdom
  • Association of Breast Surgery
    • Management of the Malignant Axilla in Early Breast Cancer [2015]
  • Clinical Oncology
    • Axillary Surgery Following Neoadjuvant Chemotherapy – Multidisciplinary Guidance From the Association of Breast Surgery, Faculty of Clinical Oncology of the Royal College of Radiologists, UK Breast Cancer Group, National Coordinating Committee for Breast Pathology and British Society of Breast Radiology [2019]
  • National Institute for Health and Care Excellence
    • Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer [2022]
    • Intraoperative tests (RD-100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer [2013]
    • Endoscopic axillary lymph node retrieval for breast cancer [2005]
• United States
  • American Society of Clinical Oncology
    • Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update [2017]
    • Management of the Axilla in Early-Stage Breast Cancer
  • Annals of Surgical Oncology
    • Do the ACOSOG Z0011 Criteria Affect the Number of Sentinel Lymph Nodes Removed? [2015]
  • BMC Surgery
    • DCIS and axillary nodal evaluation: compliance with national guidelines [2017]
  • Breast Cancer Research and Treatment
    • Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough? [2020]
  • JAMA Network Open
    • Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US [2022]
  • Journal of Surgical Research
    • Disparities of Management of the Axilla in Women With Clinically Node Negative Breast Cancer [2020]
• Venezuela
  • ecancermedicalscience
    • Treatment plan for breast cancer with sentinel node metastasis [2014]
• {Related topics}
  • Guidelines
    • Breast cancer
    • Breast biopsy, breast pathology

Triple negative breast cancer

• Australia
  • Hereditary Cancer in Clinical Practice
    • Assessment of genetic referrals and outcomes for women with triple negative breast cancer in regional cancer centres in Australia [2021]
  • Medical Services Advisory Committee
    • PD-L1 (Programmed Death Ligand 1) immunohistochemistry (IHC) testing for access to atezolizumab as first line therapy for patients with locally advanced or metastatic triple-negative breast cancer (TNBC) [2021]
• Barbados
  • Cancer
    • High triple-negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancer [2020]
• Finland
  • Breast Cancer Research and Treatment
    • FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population [2017]
• Germany
  • BMC Cancer
    • Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9156 patients [2013]
  • Geburtshilfe und Frauenheilkunde
    • Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) – Recommendations for Daily Routine Practice [2019]
• India
  • JCO Global Oncology
    • Meta-Analysis of Prevalence of Triple-Negative Breast Cancer and Its Clinical Features at Incidence in Indian Patients With Breast Cancer [2020]
  • South Asian Journal of Cancer
    • Practical consensus recommendations on management of triple-negative metastatic breast cancer [2018]
• International
  • Cancers
    • Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer [2021]
• Italy
  • Cancers
    • Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM) [2019]
• Mexico
  • Breast Cancer Research and Treatment
    • The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer [2015]
• Republic of Korea
  • PLoS ONE
    • Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population [2015]
• Thailand
  • PLoS ONE
    • Real-life clinical pattern, management, and survival in Thai patients with early-stage or metastatic triple-negative breast cancer [2018]
• United Kingdom
  • National Institute for Health and Care Excellence
    • Sacituzumab govitecan for treating unresectable triple-negative advanced breast cancer after 2 or more therapies [2022]
    • Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancer [2022]
    • Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced breast cancer [2022]
    • Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer [2020]
  • SpringerPlus
    • The treatment and survival of patients with triple negative breast cancer in a London population [2014]
• United States
  • Breast Cancer Research and Treatment
    • Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing [2014]
  • JAMA Network Open
    • Clinical and Demographic Factors, Treatment Patterns, and Overall Survival Associated With Rare Triple-Negative Breast Carcinomas in the US [2021]
  • Oncologist
    • Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer: Clinical Overview and Management of Potential Toxicities [2021]
• West Africa
  • JCO Global Oncology
    • Prevalence and Mortality of Triple-Negative Breast Cancer in West Africa: Biologic and Sociocultural Factors [2021]
• {Related topics}
  • Guidelines
    • Breast cancer